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ABSTRACT 
Antibiotic resistance in clinical bacterial isolates remains an ongoing problem requiring 
continuous monitoring to effect some form of control. Comparative studies have not 
been previously reported for the Eastern Cape Region, South Africa and this study was 
undertaken to monitor resistance patterns in clinical isolates from Provincial Hospital, 
Port Elizabeth. Over the three year period 1989 to 1991, 9888 susceptibility results from 
isolates examined in the SAIMR pathology laboratory were analysed and collated using 
a stand· alone computer program. Resistance patterns for a range of nineteen antibiotics 
were collated for isolates from various sampling points within the hospital. Results were 
reported as resistance patterns in individually isolated species. Levels of resistance in 
each species were compared to those reported from South Africa and abroad, and 
changing patterns of resistance were noted within the three year period at the Provincial 
Hospital, Port Elizabeth. 
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ABBREVIATIONS 
Abbreviations used for antimicrobial agents and organisms on the graphs. 
PEN = Penicillin 
AMP = Ampicillin 
PE/AP = Penicillin! Ampicillin 
PIP = Piperacillin 
CDL = Cefamandole 
TET = Tetracycline 
COT = Cotrimoxazole 
ERY = Erythromycin 
CLI = CIindamycin 
PUC = Fucidin 
GEN = Gentamicin 
TOB = Tobramycin 
AMI = Amikacin 
FOZ = Cefoxitin 
TAX = Cefotaxime 
VAN = Vancomycin 
IMI = Imipenem 
TAZ = Ceftazidime 
OFL = Ofloxacin 
XlV 
CIP = Ciprofioxacin 
NOR = Norfloxacin 
Aani = Acinetobacter anitratus 
Eclo = Enterobacter cloacae 
Ecol - Escherichia coli 
Kaer = Klebsiella aerogenes 
Pmir = Proteus mirabilis 
Smar = Serratia marcescens 
Paer = Pseudomonas aeruginosa 
Xmal = Xanthomonas maltophilia 
CHAPTER! 
1. INTRODUCTION 
The use of antimicrobial agents has been described as the greatest intervention ever in 
population genetics. The selective pressures of antimicrobial agents have provoked the 
emergence of resistance to drugs among many previously susceptible bacteria of clinical 
significance. Antibiotic resistance is a worldwide problem especially in developing 
communities and hospitals. It limits the number of useful antimicrobial agents, places 
constraints on those which can be used and may cause the usage of more toxic and/or 
more expensive agents (van den Ende, 1989). 
In the hospital setting, the effectiveness of antibiotic treatment may be seriously 
compromised by resistance that is either intrinsic to the hospital flora or develops during 
the course of therapy (Buirma & Horrevorts, 1991). In vitro antimicrobial susceptibility 
tests provide useful information to direct clinicians in their choice of antibiotics for 
treatment of infections. Such tests can also be used to generate antibiograms that serve 
as tools for selecting antimicrobial agents to treat infection caused by identified 
pathogens prior to the availability of the susceptibility test reports for those pathogens 
(Jenkins, 1992). Therefore; antimicrobial susceptibility patterns are of great importance 
in a hospital environment as medical staff often need to treat life-threatening situations 
empirically i.e. before antimicrobial test results are available. 
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The high cost of empiric therapy, usually an extended spectrum new J3-lactam agent 
combined with an aminoglyoside, should encourage more rational use of more specific, 
less costly, and potentially less toxic antibiotics based on the isolation, identification and 
susceptibility test results provided by the microbiology laboratory. The laboratory in 
tum should also keep the medical staff abreast of changes in antimicrobial susceptibility 
patterns (Washington, 1984). 
Approximately one third of patients admitted to hospitals receive antimicrobial drugs. 
Such antibiotic use causes coincidental changes in the flora of individual patients and in 
the hospital locale. These changes have an important influence on the prevalence and 
character of nosocomial infections. The frequency of emergence of antibiotic-resistant 
organisms within a hospital or ward varies from place to place and is proportional to the 
degree of use of the specific antimicrobial drugs tested (Daschner & Borneff, 1977). 
Restrictions on the use of certain antibiotics may be reco=ended in some hospitals, but 
have little effect on the prevalence of nosocomial infections and the purpose is to 
minimise the problem of antibiotic resistance and favourably influence the treatment of 
those infections that occur. 
Each Provincial Hospital has an antibiotic policy, often slightly different from other 
hospitals, and the only assistance the doctors have available to them regarding resistance, 
is what they glean from the laboratory reports and the information published quarterly 
by the Antibiotic Study Group of South Africa (A.S.G.S.A.) in The South African 
Medical Journal. This data consists of the number of isolations and the incidence of 
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antibiotic resistance from seven academic training hospitals in South Africa from 
cerebrospinal fluid and blood cultures. As Port Elizabeth does not fall in this category, 
this information is of little help to the local doctors. Each hospital needs to have access 
to its own resistance data as this does vary from hospital to hospital and indeed between 
different sections of the same hospital (Friedland, 1990). Because of this fact very little 
information is published because it is considered of little consequence to other hospitals. 
Thus, an understanding of the epidemiology of resistant species and resistance patterns 
and a knowledge of those combinations of drugs and microbes with a high probability 
of developing resistance are critical for the clinician in choosing appropriate antimicrobial 
regimens. Such an understanding can be achieved through surveillance studies (Buirma 
& Horrevorts, 1991). Appeals from clinicians have appeared in the literature for more 
specific data covering (i) a comparison of antimicrobial sensitivities in different hospitals 
and in different sections of each hospital especially high-care areas, (ii) the changes in 
sensitivity patterns with changes in antibiotic policy and with time, and (iii) sensitivity 
patterns to antibiotics such as amikacin and the newer antibiotics e.g. ciprofloxacin and 
imipenem (Friedland, 1990). 
The following micro-organisms have been isolated the most frequently in the Provincial 
Hospital Port Elizabeth (PHPE) and are cited as the most co=on nosocomial 
pathogens in the literature (Crowley & Edwards, 1986; Smith & Eng, 1989). The aim 
of this study is thus to examine the antibiotic resistance patterns of these organisms in 
PHPE. 
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GRAM-POSITIVE COCCI: 
Staphylococcus aureus including Methicillin resistant strains (MRSA). 
Staphylococcus epidermidis including Methicillin resistant strains (MRSE). 
Enterococcus faecalis. 
Enterococcus faecium. 
GRAM-NEGATIVE BACILLI: 
Acinetobacter anitratus. 
Enterobacter cloacae. 
Escherichia coli 
Klebsiella aerogenes. 
Proteus mirabilis. 
Pseudomonas aeruginosa. 
Serratia marcescens. 
Xanthomonas maltophilia. 
1.1. GRAM-POSITIVE COCCI 
During the early 1980's a resurgence of Gram-positive cocci causing severe infection was 
noted (McGowan, 1988). Much of this increase was closely associated with the 
development of antimicrobial resistance in several genera. 
The Centres for Disease Control (CDC) in the U.S.A. initiated a national surveillance 
programme for hospital infection, the National Nosocomial Infections Study (N.N.lS.) 
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and in 1984, three groups of Gram-positive cocci, S. aureus, S. epidennidis and Group D 
Streptococci, were found to account for 34% of all bloodstream pathogens (Horan et al., 
1986). 
Staphylococci are members of the Micrococcaceae family which includes two genera: the 
micrococci and the staphylococci. The staphylococci in tum, have 3 clinically important 
species: S. aureus, S. epidennidis and S. saprophyticus (pfaller & Herwaldt, 1988; 
Sheagren, 1984). They are non-motile, non-sporeforming, gram-positive, facultatively 
anaerobic, clustering cocci that produce catalase (Pfaller & Herwaldt, 1988). S. aureus 
continues to be a pathogen of major importance. The organism has developed 
mechanisms of circumventing almost every attempt to control it, either by host's defences 
or by newer antibiotic agents (Brumfitt & Hamilton, 1989; Sheagren, 1984). 
Staphylococci are still the most common agents implicated in hospital-acquired infections. 
In addition to S. aureus, S. epidennidis has attracted widespread interest, since these two 
species have emerged as the most frequent pathogens in foreign-body related infections. 
The emergence of MRSA has resulted in increasing use of potentially toxic and 
extremely expensive antibiotics (Kappstein & Daschner, 1991). 
1.1.1. STAPHYLOCOCCUS AUREUS 
Historically S. aureus has been recognised as one of the most devastating human 
pathogens. Initially, the organism proved to be susceptible to the earliest antimicrobial 
substances, the sulphonamides and penicillin (Sheagren, 1984). However, as antibiotic 
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use increased through the 1950's, resistance rapidly developed (Brumfitt & Hamilton, 
1989; Shanson, 1981; Sheagren, 1984). 
Tetracyclines were increasingly used during the 1950's and by the late 1950's, outbreaks 
of infections occurred due to penicilIin- and tetracycline-resistant S. aureus strains. 
Erythromycin was widely used to treat these infections and soon resistance emerged to 
this agent, rapidly in some hospitals but only after many months in others (Shanson, 
1981). 
In the mid and late 1960's multiple antibiotic-resistant strains of S. aureus continued to 
cause frequent outbreaks of hospital infection. However, there was a gradual general 
decline in multiple antibiotic resistance compared with the late 1950's and early 1960's 
throughout the world. A major change during the 1960's included the introduction of 
methicillin which was penicilIinase stable (Shanson, 1981). 
In the 1970's and 1980's MRSA strains emerged. By 1986 MRSA strains accounted for 
10% of S. aureus in large teaching hospitals, 6% in non-teaching hospitals and 4,6% in 
smaJI teaching hospitals in the U.S.A. (McGowan, 1988). 
HistoricaJIy, S. aureus has gained increased resistance to antibiotics (Brumfitt & 
Hamilton, 1989). This org;anism has shown itself to be a remarkably versatile pathogen 
capable of causing a range of infections more diverse than most other bacterial genera. 
It has maintained its role as one of the co=onest human pathogens at various sites in 
both co=unity-acquired and hospital-acquired infection (Eykyn, 1988). S. aureus has 
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become a major clinical pathogen and a leading cause of nosocomial infections (Uu & 
Buescher, 1990; van den Ende, 1989). 
Bauer et at. (1960) found that about 80% of S. aureus were resistant to penicillin and that 
erythromycin resistance gradually increased from 14% to 31% over the 5 year period, 
1955 - 1959. 
In their review Dagan et al. (1992) reported that during the last decade, the sensitivity 
to erythromycin of S. aureus strains isolated from impetigo was ± 90% or higher. 
Recently however, erythromycin resistance rates of 32% and 48% were reported from 
Israel and Australia respectively. This change together with evidence of resistance to 
penicillin and erythromycin in their region prompted the reviewers to undertake a 
prospective study. They found that 28% of S. aureus strains were resistant to 
erythromycin. 
In a multicentre study conducted by the Paul Ehrlich Society, S. aureus strains isolated 
from West Germany, Austria and Switzerland were tested against 12 antibiotics between 
1976 and 1982. They found a significant difference in the number of susceptible strains 
between the different centres (Table 1.1.) and were unable to demonstrate significant 
changes from 1976 to 1982 for any antibiotic (Wiedemann & Kresken, 1984). 
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Table 1.1. Percentage of susceptible S. aureus strains from different European 
laboratories (Wiedemann & Kresken, 1984). 
Lubeck Bonn Berlin Munich Vienna Zurich 
Penicillin 28,2 25,8 34,0 33,0 13,0 26,1 
Oxacillin 99,0 99,7 98,8 99,1 82,1 98,7 
Gentamicin 93,2 94,0 80,9 93,9 49,6 96,2 
Tetracycline 79,6 87,3 72,2 82,6 43,1 72,6 
Erythromycin 81,9 92,0 74,5 89,6 44,7 73,2 
Lincomycin 99.0 98,8 99,4 100 96,7 99,4 
Cotrimoxazole 86,7 92,3 75,3 83,5 46,3 72,6 
The sensitivity pattern to different antibacterial agents of S. aureus from the hospital 
personnel in a Nigerian hospital were reported as resistant to penicillin 95%, methicillin 
0%, tetracycline 57,6%, cotrimoxazole 10,1% and gentamicin 8,6% (Olusanya & 
Ogeunledun, 1991). 
In South Africa, data obtained in 1987 from A.S.G.S.A. centres showed S. aureus to be 
the most co=on blood culture isolated overall, of which 41,7% (range 23,5 - 66,3%) 
were MRSA (van den Ende, 1989). 
In 1987 at the King Edward Hospital, Durban resistance rates for 413 blood culture 
isolates of S. aureus were: methicillin 29%, tetracycline 24%, erythromycin 17%, 
cotrimoxazole 14%, gentamicin 16%, clindamycin 1%, fusidic acid 0% and vancomycin 
0% (van den Ende, 1989). 
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1.1.2. METIIICILLIN RESISTANT STAPHYLOCOCCUS AUREUS 
MRSA strains were detected in the U.K. in 1960 soon after methicillin became available 
(Duckworth & Lothian, 1988; Eykyn, 1988; Shanson, 1981). 
In the late 1970's, outbreaks of gentamicin-resistant methicillin-sensitive S. aureus and 
gentamicin-resistant MRSA were reported (Casewell, 1986; Eykyn, 1988). During the 
1980's there was a sharp increase in the outbreaks of methicillin resistance in many parts 
of the world; U.K., Eire, U.S.A., Australia and South Africa (Casewell, 1986; Eykyn, 
1988; Faoagali et al., 1992). These epidemic strains are generally resistant to most anti-
staphylococcal agents except vancomycin (Eykyn, 1988). They have been termed 
epidemic MRSA (EMRSA) because of their remarkable ability to spread within 
hospitals; some affected hospitals have reported up to 40% of their clinical isolates of 
S. aureus as MRSA (Eykyn, 1988; Shanson, 1981). Eykyn (1988) listed the main 
antibiotic sensitivities of S. aureus and S. epidermidis from patients in St Thomas 
Hospital, London (Table 1.2.). 
Table 1.2. Percentage resistance of S. aureus and S. epidermidis hospital acquired 
isolates from bacteraemic patients (Eykyn, 1988). 
Resistant to s. aureus S. epidermidis 
Penicillin 88% 91% 
Methicillin 3% 43% 
Gentamicin 5% 51% 
Fnsidic Acid 2% 21% 
Erythromycin 8% 36% 
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In the U.S.A. in the 1980's MRSA increased in all types of hospitals and was widespread 
throughout the country, the first report of an outbreak in the U.S.A. having come from 
Boston in 1968 (Brumfitt & Hamilton, 1989; McGowan, 1988). Ndawula et al. (1991) 
reported an outbreak of MRSA that showed resistance to cefuroxime, cefotaxime, 
piperacillin, ceftazidime, erythromycin and gentamicin, and sensitivity to fusidic acid, 
ciprofloxacin, tetracycline and vancomycin. Maple et al. (1989) determined antibiotic 
resistance patterns for 106 strains of MRSA from 21 countries. Twelve of the 15 highly 
multiresistant strains (resistant to either thirteen or fourteen agents) came from France, 
Turkey and Brazil. Resistance to the aminoglycosides and erythromycin was recorded 
in more than 90% of the isolates. All strains were sensitive to vancomycin. Resistance 
to other agents was as follows: tetracycline 86%, clindamycin 66%, fusidic acid 12%, 
ciprofloxacin 17%. Mulligan et al. (1988) found that there was an apparent acquisition 
over time of resistance to cotrimoxazole and gentamicin by endemic strains of 
oxacillin-resistant S. aureus. 
Infections caused by MRSA stains are a serious medical problem because only a few 
effective therapeutic agents are clinically available (Brumfitt & Hamilton, 1989; Faoagoli 
et al., 1992; Harnett et ai., 1991; Nakanishi et al., 1991; van den Ende & Rotter, 1986). 
In New York City, 5,2% of S. aureus strains were quinolone resistant of which 93,9% 
were resistant to methicillin (Schaefler, 1989). In an Acute-Care Teaching Hospital, 
New York, ciprofloxacin-resistant MRSA isolates increased from ± 10% to 92,3% after 
11 months of ciprofloxacin usage. Methicillin sensitive isolates remained uniformly 
susceptible 98,4% (Raviglione et at., 1990). In another hospital the prevalence of 
quinolone resistance increased from 15 to 48% during a 6 month period. In Israel it 
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was noted that following the introduction of routine tests for quinolone susceptibility in 
August 1987, most clinical isolates of S. aureus were resistant to both methicillin and 
quinolones (Shalit et at., 1989). In Canada, Harnett et at. (1991) found that 49% of the 
MRSA isolates were resistant to ciprofloxacin, 98% resistant to tobramycin, and 42% to 
gentamicin. Daum et at. (1990) demonstrated a marked emergence of resistance to 
ciprofloxacin among S. aureus. From 1984 to 1985 all isolates were susceptible to 
ciprofloxacin regardless of whether they were methicillin resistant or susceptible. 
Isolates of MRSA from 1989 showed a significant increase in resistance to ciprofloxacin; 
55,1 % of MRSA isolates and 2,5% of S. aureus (methicillin sensitive strains) were 
resistant to ciprofloxacin. 
1.1.3. STAPHYLOCOCCUS EPIDERMIDIS 
The coagulase negative staphylococci, with the exception of the urinary pathogen S. 
saprophyticus, are secondary pathogens - opportunists, rarely able to cause infections 
without the assistance of prostheses or intravascular or other catheters (Eykyn, 1988). 
These staphylococci were long regarded only as laboratory contaminants, which of course 
they still sometimes are (pfaller & Herwaldt, 1988; Sheagren, 1984). Most routine 
laboratories use the nomenclature S. epidermidis, conveniently if inaccurately, to 
encompass all coagulase-negative staphylococci other than S. saprophyticus (Eykyn, 1988). 
In this thesis the name S. epidermidis will be used. 
Coagulase-negative staphylococci have become formidable nosocomial pathogens and are 
the leading cause of nosocomial bacteraemia in the U.S.A., a situation due in large part 
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to their propensity for infecting in-dwelling intravascular devices (Archer, 1988; Pfaller 
& Herwaldt, 1988). Some strains produce a viscous extracellular substance or slime 
which enhances adherence to prosthetic devices. A major determinant of both the 
prevalence of these organisms in hospitals and the virulence of the infections they cause 
is their resistance to multiple antimicrobial agents (Archer, 1988) 
The incidence of infection caused by S. epidermidis has increased strikingly over the past 
few years and in some types of hospital-acquired infection they are as common a 
pathogen as S. aureus. Furthermore, they are much more likely than S. aureus to be 
multiresistant (Eykyn, 1988; McGowan 1988). It has been shown that S. epidermidis may 
serve as the reservoir for transfer of resistance to S. aureus (Archer, 1988; McGowan 
1988). The multiresistant phenotype can be defined as one that encompasses resistance 
to methicillin and at least 3 other unrelated classes of antibiotics (Archer, 1988). 
Coagulase-negative staphylococci are overall more resistant to antibiotics than S. aureus 
(Davies et ai., 1986; van den Ende, 1989). 
1.1.4. ENTEROCOCCUS SPECIES 
These organisms, primarily E. faecaiis and E. faecium, are now the third most common 
organisms found in nosocomial infections and have a remarkable number of both 
intrinsic and acquired resistances (George, 1989; Gray et ai., 1991; Murray, 1990). In 
the N.N.I.S report of 1984 (Horan et ai., 1986), enterococci were the third most frequent 
source of nosocomial urinary tract infection and the sixth most frequent organisms in 
nosocomial bacteraemia. Resistant enterococci were encountered between mid - 1970's 
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and mid - 1980's in the U.S.A. (McGowan, 1988). The resistant strains have appeared 
most often in areas where antimicrobial use is high, such as that of intensive care 
(Bingen et ai., 1991; Gray et ai., 1991; McGowan, 1988; Oster et ai., 1990). Emerging 
drug resistance and increasing clinical significance of enterococcal isolates have created 
a need for accurate identification of species and surveillance of resistance patterns within 
this group (Bryce et ai., 1991). 
Most strains of enterococci are relatively resistant to penicillin and ampicillin, E. faecium 
more so than E. faecaiis (George & Uttley, 1989; Sapico et ai., 1989). Bryce et ai. 
(1991), tested 140 strains of enterococci and found that high-level gentamicin resistance 
was seen in 12,1% of isolates. None of the isolates were vancomycin resistant and 
ampicillin resistance was 2,9%. These isolates were identified as E. faecium. In the 
United Kingdom in 1991 ampicillin resistance was not found in E. faecaiis isolates. 
However, of E. faecium isolates 63,2% were resistant to ampicillin. The overall 
ampicillin resistance rate in enterococci in the hospital was 10,6% (Gray et ai., 1991). 
In California, Oster et ai. (1990) found that 9,0% of all clinical enterococcal isolates were 
resistant to ampicillin. 
Vancomycin has been successfully used as a single therapeutic agent against the 
enterococci and has shown good activity. Since the mid - 1980's, however, the 
development of resistance has become an increasing problem (Bingen et ai., 1991; Guiot 
et ai., 1991; Uttley et ai., 1989). 
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1.2. GRAM-NEGATIVE BACILLI 
The family Enterobacteriaceae comprises numerous inter-related genera all of which are 
Gram-negative bacilli and microscopically indistinguishable. Other Gram-negative bacilli 
included in this study are A. anitratus, P. aeruginosa, and X mattophilia. 
Gram-negative bacilli (GNB) are co=on causes of hospital acquired infections 
especially in patients admitted to intensive care units (ICU). 
1.2.1. ACINETOBACTER ANITRATUS 
A. anitratus is an oxidase-negative, gram-negative cocco-bacillus often found in moist 
areas of the skin such as the groin, axilla, and the webbing of the toes. Widely prevalent 
in nature, the organism is considered to be a human co=ensal but can also be an 
important cause of nosocomial infections. Acinetobacter species are often resistant to 
multiple antimicrobial agents (Lambert et at., 1990; Le Maistre et at., 1985) 
1.2.2. ENTEROBACTER CLOACAE 
E. cloacae is increasingly recognised as an important pathogen and has been implicated 
in many episodes of hospital acquired infections, involving a high incidence of 
multiresistance (Gaston, 1988; John et at., 1982; The Greek Society for Microbiology, 
1989). 
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1.2.3. ESCHERICHIA COLI 
E. coli has remained the most frequently isolated nosocomial pathogen in U.S. hospitals 
accounting for approximately 18,6% of hospital-acquired infections (Crowley et ai., 1986). 
1.2.4. PSEUDOMONAS AERUGINOSA 
P. aeruginosa is a particularly problematic pathogen and is a major cause of nosocomial 
infections (Korvick & Yu, 1991; Morrison & Wenzel, 1984). It is also the pathogen 
most responsible for morbidity and mortality in patients with cystic fibrosis. Mortality 
rates for P. aeruginosa bacteraemia ranged from 79 - 96% in the 1950's. Colistin, 
released in 1959, was the first antimicrobial agent with significant in vitro activity against 
P. aeruginosa. However, therapeutic efficacy failed to match in vitro susceptibility, and 
colistin was replaced by gentamicin and carbenicillin in the 1960's. A mortality rate of 
71 % was stilI found for bacteraemic patients treated with gentamicin and before long 
resistance to carbenicillin emerged. The pharmaceutical industry responded with a host 
of anti-pseudomonal agents eg.: ceftazidime, piperacillin, imipenem and ciprofloxacin 
(Korvick & Yu, 1991). 
Bosso et at. (1989) evaluated and monitored susceptibility patterns of P. aeruginosa 
isolates collected from a Cj'stic fibrosis (CF) population to ciprofloxacin, aztreonam and 
ceftazidime and seven other anti-pseudomonaJ agents, before use, during the early stages 
of use, and later after introduction of the three new antibiotics. They also studied 
concomitant resistance patterns among these ten agents during those same time periods. 
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Ciprofloxacin, piperacillin, ceftazidime and tobramycin showed decreases in susceptibility 
of9,5%; 6,4%; 14,3% and 12,2% respectively. Gentamicin remained stable and amikacin 
showed an increase in susceptibility over the time period. Ciprofloxacin and ceftazidime 
were the newly introduced antibiotics. The decline in the rate of susceptibility to 
ceftazidime (14,3% resistant) could reflect ,the extensive use of this agent in their CF 
patients. Concomitant resistance within and among antibiotic classes was co=on. 
1.2.5. SERRATIA MARCESCENS 
S. marcescens has easily acquired resistance to many antibiotics and has been recognised 
as an important nosocomial pathogen (Fujimaki et at., 1989). 
1.2.6. XANTHOMONAS MALTOPHILIA 
X mattophilia is an important cause of nosocomial infections, especially in 
i=unocompromised patients. Although cotrimoxazole remains the drug of choice, a 
significant number of patients are unable to tolerate this agent. The organism is 
isolated from a wide variety of clinical sources, including blood, the respiratory tract, 
urine, wounds and spinal flnid and from environmental sources ego hospital water 
supplies, faucets, sinks, drains, respiratory and disinfectant solutions (Khardori et at., 
1990). 
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Aminoglycoside resistance is a major problem in South Africa. Although rates vary 
between centres, all have problems. In 1987, the AS.G.S.A reported gentamicin 
resistance figures in Blood Culture isolates (Table 1.3.) (van den Ende, 1989). 
Table 1.3. Percentage resistance of South African isolates from Blood Cultures to 
gentamicin (van den Ende, 1989). 
Organism % Resistance Range 
E. coli 4,1% 1,9 22,0% 
Klebsiella spp. 30,3% 18,5 44,3% 
Enterobacter spp. 15,3% 1,7 44,4% 
P. aeruginosa 35,2% 11,1 42,1% 
Van den Ende & Rotter (1986) analysed data on blood culture isolates for 1983 and 
January - July 1984 that has been reported by the AS.G.S.A. and found disturbingly high 
resistance to gentamicin among Gram-negative bacilli. Over 30% of total isolates of 
Klebsiella spp. were resistant. In Pretoria and Bloemfontein over 10% of E. coli isolates 
were resistant. The overall prevalence of gentamicin resistance to Enterobacter spp. and 
Pseudomonas spp. was 6 - 8% and ± 25% respectively. Gentamicin is the 
aminoglycoside antibiotic most widely used in S.A. in the therapy of serious infections 
caused by GNB and has therefore been used as an indicator antibiotic for this group. 
In the academic hospitals in the Johannesburg area the overall amikacin resistance in 
Gram-negative bacilli is ± 5%; at Hillbrow Hospital it is 5,5% and at Baragwanath 
Hospital 5,0%. In some of the ICU's the resistance is much higher i.e. in the Neonatal 
ICU at Baragwanath it is 13%. Eighteen percent of the isolates from pus specimens at 
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the Johannesburg Hospital are resistant to amikacin (Liebowitz & Koornhof, 1990). 
The bacteria isolated in hospitals that demonstrate this resistance are predominantly 
Acinetobacter, Pseudomonas and Klebsiella species. The authors reported that their 
findings were in contrast to those reported by Hesseling et at. (1989) from Tygerberg 
Hospital. Their study showed virtually no increase in amikacin resistance after almost 
exclusive use in the medical paediatric wards for an 18 month period (Hesseling & van 
der Merwe, 1989). 
In Pakistan it was found that there was a high incidence of drug resistance to ampicillin 
and gentamicin among GNB (mean = 67%) in the neonatal unit at Aga Khan University 
Hospital (Karachi). A condensed summary of the percent of resistant strains to 
commonly used antibiotics is given in Table 1.4. (Bhutta et at., 1991). 
Table 1.4. Antibiotic resistance pattern of common organisms isolated in Pakistan. 
The figures indicate the percentage of resistant strains (Bhutta et al., 
1991). 
No. of Gentamicin Amikacin Ampicillin Cefoxitin 
Isolates 
E. coli 8 43% 29% 86% 14% 
Klebsiella spp. 17 59% 6% 100% 24% 
Enterobacter spp. 3 33% 0% 33% 0% 
Serratia spp. 4 100% 0% 100% 0% 
Pseudomonas spp. 7 43% 14% 86% 43% 
In Riyadh, the capital of the Kingdom of Saudi Arabia, a survey was undertaken to 
determine the prevalence of gentamicin resistance. Table 1.5. contains a summary of 
their results (Moaz et at., 1989). 
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Table 1.5. Percentage of gentamicin resistance in Riyadh, Saudi Arabia (Moaz et aI., 
1989). 
% of Resistance to Gentamicin 
E. coli 
Klebsiella spp. 
Ent. cloacae 
Serratia spp. 
Proteus nrirabi1is 
Acinetobacter spp 
Ps. aeruginosa 
1,6 
8,6 
9,3 
20,7 
15,0 
37,2 
26,6 
Previous studies in Riyadh in 1978 and 1983 showed no gentamicin resistance in E. coli 
or Klebsiella spp. and a level of 1,6% in P. mirabilis isolates. 
In 1983 and 1984 a survey of resistance ofP. aeruginosa to aminoglycosides and f3-lactam 
antibiotics was conducted in the Netherlands. Ten percent of the isolates were resistant 
to gentamicin. Although tobramycin was slightly more active than gentamicin, 
cross-resistance was nearly complete. Nearly all the gentamicin-resistant strains were 
susceptible to amikacin. Nine percent of the isolates were resistant to carbenicillin and 
0,6% to ceftazidime (NeeJing et ai., 1987). 
1.3. INTENSIVE CARE 
Intensive Care Unit (lCU) patients represent the most severely ill segment of the 
hospitalized population. Acquisition of infection in the leu is associated with a grave 
prognosis. Awareness of patterns for nosocomial infections and the causative pathogens 
in different units may be of value in selecting empiric therapy. 
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Available data on the characteristics of infections in different types of ICU's are limited. 
Device-related infections involving urinary and respiratory tracts were the most co=on. 
Predominant pathogens isolated in order of frequency were E. coli, P. aeruginosa, 
K pneumoniae and S. aureus (Chandrasekar et ai., 1986; Thorp et ai., 1979). 
Stratton (1990) found that when hospital-wide susceptibility patterns in the VanderBilt 
University Hospital were examined over several years no major changes were observed. 
However, when the data were analysed on a unit-by-unit basis, striking differences were 
found between the patterns of hospital-wide isolates and those of specific units 
particularly the ICU's. 
1.4. ANTIBIOTIC USAGE 
Organisms resistant to antimicrobial agents have more than epidemiologic significance. 
Resistance can affect the ease with which the afflicted patients can be treated, and this 
in turn may affect the outcome of the patient's illness. 
McGowan (1983) reviewed the literature and reported that, "A causal relationship 
between antibiotic usage and resistance of hospital organisms is supported by consistent 
association and concurrent variation in several populations, presence of a dose - response 
pattern, and existence of a reasonable biologic model to explain the relationship. 
Virtually all reports agreed that careful, discriminating use of antimicrobial agents 
remains the keystone for minimizing this problem". 
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Davies et al. (1986) showed that aminoglycoside resistance in coagulase-negative 
staphylococci is affected by previous exposure to aminoglycosides. 
The effects of long-term use of amikacin on bacterial resistance to the aminoglycosides 
has been evaluated quite often. All reports concur that resistance to amikacin did not 
increase and in some instances, e.g. K pneumoniae resistance to gentamicin, netilmicin 
and tobramycin decreased significantly (HesseJing & Mouton, 1990; Gerding & Larson, 
1985; Gerding et al., 1991; Moody et aI. , 1982; Muscato 1991). 
In 1978 O'Brien et al. found the prevalence of bacterial resistance to antibiotics to be 
substantially different in two separate regions of the world, namely Paris and Boston. 
The comparison indicated that resistance was more prevalent in the flora of patients in 
Paris than Boston during the period studied. This, they suggested, was due to difference 
in the bacterial flora of their communities and that similar systematic comparisons of 
resistance prevalence in different parts of the world might help to define optimal 
antibiotic usage practiCes. Information about the prevalence of resistance is essential to 
the rational use of antibiotics. 
In 1977, Koornhof blamed the emergence of resistant strains largely on injudicious and 
over-use of antibiotics by doctors in the past. In 1989, Miller concluded that the 
majority of today's problems of antibiotic abuse developed in an era where there were 
no guidelines on appropriate use or restraint on the cost of medical care. The 
Antibiotic Control Committee or Pharmacy and Therapeutics Committee in a hospital 
should play a decisive role in keeping to a minimum the number of agents needed for 
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optimum therapy, and in publicising guidelines for medical staff to select the least 
expensive yet effective agent from a drug class. The results of properly undertaken 
susceptibility tests by the microbiology laboratory have an important role in influencing 
antibiotic therapy. Various surveys have been carried out and show that there is a high 
proportion of antibiotic misuse (Aswapokee et al., 1990; Miller, 1989; Till et al., 1991). 
1.5. MECHANISMS OF DRUG RESISTANCE 
The emergence of antibiotic resistance is a major factor limiting long-term successful use 
of an antimicrobial agent. The term 'antimicrobial agent' covers all substances whether 
naturally occurring, synthesized or semi-synthetic but is not very precise as it includes 
other substances such as disinfectants. Antibiotics are substances that are obtained from 
micro-organisms and are able to inhibit or kill other micro-organisms. Chemotherapeutic 
substances have similar activity but are obtained by chemical processes rather than 
derived from biological sources. 
The term "Antibiotic" is now often used as a trivial name to cover all these substances 
except disinfectants and will be used in this context in the thesis. Antibiotics differ from 
disinfectants in being precisely directed against specific targets in the micro-organisms. 
Antibiotics have a defined spectrum of activity. Some bacteria are naturally resistant 
to some antibiotics and naturally sensitive to others. The use of antibiotics will reduce 
or eliminate the numbers of sensitive bacteria creating a ecological niche which will be 
filled by bacteria which are naturally resistant to that antibiotic. 
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1.5.1. GENETICS OF RESISTANCE 
Resistance to antibiotics can be divided into that which is intrinsic (i.e. a naturally 
occurring trait) and that which has been acquired. 
Naturally occurring resistance is shared by most or all of the species and for this reason 
can be considered a species characteristic (e.g. resistance of E. coli, K pneumoniae and 
Enterobacter species to oxacillin, clindamycin and vancomycin). Intrinsic resistance does 
not really pose a clinical problem since this resistance is discovered during the early 
phases of development of a new compound and thus clinical efficacy is never an 
expectation. 
Acquired resistance implies that a susceptible organism has developed resistance to an 
agent to which it was previously susceptible. This can occur either by mutation(s) in the 
existing DNA of the organism, or by acquisition of new DNA. The mechanisms based 
on mutations include alterations of the target organelle in the microbial cell. 
Streptomycin for example, acts by becoming bound onto proteins derived from 30S 
subunit of the ribosomes. Cells that have acquired resistance produce the protein in an 
altered form no longer capable of binding streptomycin. 
Another mechanism is exclusion of the antibiotic from the cell, for example the 
resistance of E. coli to tetracycline. Enzymes capable of destroying or modifying the 
antibiotic might be elaborated, such as J3-lactamases capable of opening the J3-lactam ring 
of cephalosporins and penicillins. Finally, the blocked reaction could be bypassed by a 
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different pathway: resistance to trimethoprim can be brought about by modifying the 
metabolic pathway which is interrupted by trimethoprim. 
Acquisition is the transfer of DNA from one bacterium to another, and occurs by one 
of several processes (Datta, 1984; Murray & Hodel-Christian, 1991; van den Ende, 1989; 
Williams, 1984): 
• Conjugation: It is generally accepted that this is the most co=on mechanism 
of transfer of resistance genes. Cell-to-cell contact is made and DNA from one 
cell, the donor, is transferred to another cell, the recipient. The ability to conjugate 
is normally encoded by conjugative plasmids or less co=only by conjugative 
transposons. Such gene transfer occurs readily among Gram-negative bacilli and 
may occur not only between identical species but also across species and genera. 
• Transduction: This is the transfer of genes by bacteriophage particles. 
Extrachromosomal genes are transmitted by means of bacteriophages and can 
only occur between donor and recipient bacteria that share appropriate cell 
surface receptors for the transducing phage. Transduction is particularly 
important for plasmid transfer between Gram-positive cocci among which 
conjugation is less co=on. 
• Transformation: Free or naked DNA may be taken up, internalised and 
integrated into the DNA of a living bacterium. 
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• Plasmids are extrachromosomal elements of DNA that are not essential for the 
survival of bacterial cell. They vary in size from < 1 to >30Oxl06 daltons. They 
can replicate autonomously (independently of the chromosome). 
Plasmids can contain very different numbers and types of genes (Datta, 1984; Murray & 
Hodel-Christian, 1991; van den Ende, 1989; Williams, 1984), and can thus encode a 
number of different traits. A few examples of the traits that can be carried are: 
antibiotic resistance (known as resistance or R plasmids); carbohydrate fermentation; 
toxin production; bacteriocin production. Plasmids also differ in other characteristics, 
such as the ability of some plasmids to mediate their own transfer by conjugation -
conjugative plasmids. Plasmids that cannot mediate their own transfer are termed 
nonconjugative plasmids. One may see co-transfer of nonconjugative plasmids. This is 
described as mobilization and depends on the presence in the nonconjugative plasmid 
of "mobilization" or mob genes. 
Transposons are specific sequences of DNA that have the ability to move from one DNA 
molecule to another independent of the cell's homologous recombination system. Also 
termed 'Jumping genes', they are able to detach themselves from chromosomes, plasmids 
and bacteriophages and re-insert themselves into DNA elsewhere. Thus genes coding 
for resistance to a particular antibiotic may be added to a plasmid which already codes 
for resistance to one or more agents. Unlike plasmids they are not able to replicate 
independently. They must therefore be maintained as part of a functional 
self-replicating DNA molecule such as a plasmid or bacteriophage. The ability of DNA 
to move from organism to organism has had a major effect on increasing resistance. The 
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major impact of transposons on the emergence of antibiotic resistance is that they can 
expand the host range to which resistance genes can be spread. Plasmids in general have 
a narrower range of organism in which they are stable, whereas transposons are less 
restricted e.g. the ability of gram-positive transposons to transpose in gram-negative 
organisms. 
Plasmid and transposon-mediated resistance are the most co=on and important forms 
of acquired resistance and have been aptly referred to as "infectious" antibiotic resistance. 
Antibiotic resistance is increasing amongst almost all bacterial species. The 
epidemiological factors in this increase are complex (Williams, 1984) and are considered 
below: 
• acquisition of resistance by which bacteria receive their resistance genes is either 
chromosomal: mutation, tranduction and transformation or extrachromosomal 
(Plasmids): transduction and transfer. 
• mechanisms of resistance that may be present are the alteration of the target 
organ in the microbial cell, the exclusion of the antibiotic from the cell, 
elaboration of enzymes capable of destroying or modifying the antibiotic and the 
by-pass of the blocked reaction by a different pathway. 
26 
• means of dissemination of resistant organisms are case to case transfer, 
acquisition from carriers and from the inanimate environment including food. 
Virulence and transmissibility of the organism, use of antibiotics and opportunities 
for infection in a hospital are all factors influencing the spread of resistant 
organisms. 
Two types of clinical problems may arise from antibiotic-resistant bacteria, namely 
epidemic and endemic disease. Endemic diseases may cause large numbers of single 
episodes of infection creating treatment problems for individual patients. The 
acquisition of antibiotic resistance in the normal flora of man provides a gene pool of 
resistance which can either transfer to more virulent species or give rise to infection 
themselves in immunologically deficient patients (Williams, 1984). 
1.6. RESEARCH OBJECTIVES 
This project was undertaken to: 
• monitor antibiotic resistance patterns in a Port Elizabeth hospital. 
• follow pattern changes over a three year period at different sampling points within 
the hospital. 
• report, assess and compare the resistance data from the Provincial Hospital, Port 
Elizabeth, with other studies reported from South Africa and abroad. 
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• establish a computer program whereby the data could be easily collated into 
meaningful information. 
• determine whether this information was of value to the medical staff and to offer 
a continuing service of this nature to the hospital and in doing so, assist in the 
control of antibiotic resistance and the cost effective use of these drugs. 
• correlate resistance patterns with antibiotic usage in the hospital. 
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CHAPTER 2 
2. MATERIALS & METHODS 
In the 3 year study period 1989, 1990 and 1991, all specimens for microbiological 
examination from PHPE which were processed by the South African Institute for 
Medical Research pathology laboratories were included in this study. Over this 
period, 5580 patient records containing 9888 isolates with susceptibility results were 
entered into the computer program. 
Duplicate cultures from patients were excluded from this study unless the 
susceptibility pattern was significantly different i.e. sensitive changed to (became) 
resistance. This sorting was performed manually by the investigator. Special 
attention was paid to the Intensive Care Units (ICU) patients reports being kept 
together for as long as they were in the unit and each report was scrntinized for 
repeated organisms with identical susceptibility patterns. 
The organisms were identified using standard laboratory techniques including: API 
lOS, API 20E, API 20NE (API Systems, BioMerieux) for the Gram-negative bacilli, 
catalase, DNase, Staphaurex (Murex), aesculin hydrolysis, bile tolerance, pyruvate and 
6,5% NaQ for the Gram-positive cocci. In certain instances full identification was 
not carried out because either, it would mean a delay of a further day in the report 
reaching the ward, or it was deemed to be cost efficient for the hospital. 
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2.1 ANTIMICROBIAL SUSCEPTIBILITY TEST METHOD 
Numerous methods are available for testing the sensitivity of bacteria to antimicrobial 
agents. These include :-
Disc diffusion method. 
Agar diffusion / dilution method. 
Break-point determination. 
Minimum inhibitory concentration. (MIC) 
The disc diffusion method is the one commonly used in routine diagnostic 
laboratories where there is a need to combine accuracy with speed. 
There are different ways of performing disc diffusion tests, the most accepted being: 
• the International Collobrative study (ICS) 
• the Kirby-Bauer (KB) 
• the comparative method of Stokes. 
The ICS and KB methods rely for interpretation on comparing measured zones with a 
scale prepared from regression lines relating zone size to minimum inhibitory 
concentration (MIC). The comparative (Stokes) method depends on comparison 
between zones seen with the test organism and those of a known sensitive control. 
The test and control organisms are inoculated onto one plate. This method was 
employed for the purpose of this study (Stokes & Ridgeway, 1987). 
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2.2. MEDIA USED IN THIS STUDY: 
Diagnostic SensitiviD' Test (DSD Agar (MAS'D 
Formula: Beef Extract 
Uridine 
Peptone 
NaO 
Agar 
pH 
Method per litre: 
1. Suspend by swirling 37.5 g in 1 litre distilled water. 
2. Steam for 1 hour to dissolve. 
3. Autoclave at 120°C (15 p.s.i.) for 15 minutes. 
4. Cool at 50°C. 
5. Pour plates 4 mID deep. 
Saline (0.85%) 
Formula: NaO 85 g 
Distilled water 10 litres. 
Method: 
Dissolve and dispense 6 ml into tubes. 
Cap and autoclave at 121°C (15 p.s.i.) for 15 minutes. 
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7.0 g 
0.05 g 
13.5g 
5.0 g 
12.0 g 
7.3 
MacFarland 0,5 Standard (108 organisms/mIl 
Solution 1 (0.048) M BaCI) 
BaCI2 - 2H20 
Distilled Water 
Solution 2 (0,35 N H2S04) 
a) H2S04 
Distilled Water 
1,17 g 
100 mI 
0,35 mI 
99,65 mI 
b) Add 1 mI of (a) to 100 mI Distilled Water. 
Final Solution (100 mI) 
Add 0.5 mI solution 1 (0,048 M BaCI2) 
to 
99,5 mI Solution 2 (0,35 N HsS04) 
Dispense amounts into sealed containers as required by 
the laboratory. 
2.3. TEST ORGANISMS 
The test organisms used in this study were isolated in the SAIMR routine diagnostic 
laboratory from a variety of specimens. The primary isolation plates were inoculated 
directly from the specimens, each type of specimen requiring a different selection of 
plates. This was to ensure that all possible pathogens would be isolated if present. 
These plates were incubated under optimal conditions and inspected for growth the 
following day. 
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All clinically significant organisms were set aside for sensitivity and identification 
tests. Where a sensitivity result after 24 hours was useful in the case of urine 
specimens and only one organism was usually present in significant numbers a 
sensitivity test was performed directly from the urine. If the bacterial count was 
> 100,000 organisms per mI this was considered significant growth. 
If after incubation the inoculum was too heavy or too light, the test was repeated 
from the primary plates. 
2.4. METHOD OF INOCULATION 
It is not desirable to test a single colony as there may be variation in sensitivity 
(Stokes & Ridgeway, 1987). Therefore 3 to 5 discrete colonies were selected, 
touched and emulsified in saline. Inoculum density was compared with the 0.5 
MacFarland standard and adjusted if necessary. Once the turbidity was correct the 
suspension was ready for inoculation onto the sensitivity test agar. 
2.5. CONTROL ORGANISMS 
The following were the control organisms used until 30th June 1990: 
For organisms isolated from urine: 
Escherichia coli NCTC 10418 
For organisms isolated from all other sites: 
Staphylococcus aureus NCTC 6571 
For Pseudomonas species: 
Pseudomonas aeruginosa NCTC 10662 
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The control must be an organism known to respond to treatment with normal doses 
of the antimicrobial agent and the choice depends on the site of infection and the 
concentration of the drug attainable there. Agents which are excreted by the kidneys 
produce high concentrations in the urine and more resistant organisms are likely to 
respond to treatment. Therefore, a more resistant control should be used. If 
interpretation is based on the use of controls as originally defined, coliform organisms 
causing systemic infections treatable with normal doses of some agents may be 
misinterpreted as having intermediate susceptibility. This is one of the reasons why 
many laboratories have modified the method so that Gram-negative bacilli are 
compared with E. coli control and Gram-positive cocci with staphylococcus control. 
After consultation with leading microbiologists in the country the control organisms 
used were changed. The following are the control organisms used as from 1st July 
1990: 
For coliform organisms: 
Escherichia coli NCfC 10418 
For Gram-positive organisms: 
Staphylococcus aureus NCfC 6571 
For Pseudomonas species: 
Pseudomonas aerugirwsa NCfC 10662 
The DST agar plate was inoculated with the aid of a rotary plater, an instrument with 
a turntable as shown in Figure 2.1. A swab was moistened with the control organism 
and the DST agar plate inoculated from the outside towards the centre up to the 
dividing ring while the plate rotated on the turntable. This was repeated using the 
test organism but inoculating from the centre outwards to the ring. 
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Figure 2.1. The "MAST rotary plater. 
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2.6. DISCS CONTAINING ANTIMICROBIAL AGENTS 
One ring containing six discs was used per plate. Single discs were used when 
necessary. Disc concentrations of antimicrobial agents were as listed below. 
Penicillin 
Ampicillin 
Oxacillin 
Piperaci11in 
Cefamandole 
Tetracycline 
Cotrimoxazole 
Erythromycin 
Clindamycin 
Fusidic acid 
Kanamycin 
Chlorampenicol 
Gentamicin 
Tobramycin 
Neticmicin 
Amikacin 
Cefoxitin 
Cefotaxime 
Ceftazidime 
Imipenem 
Ofloxacin 
Sulfisoxazole 
Nalidixic Acid 
Nitrofurantoin 
Nicene 
Vancomycin 
Norfloxacin 
Methicillin 
Ciprofloxacin 
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2 Units 
10 ug (25 ug urine specimens) 
1 ug 
100 ug 
30 ug 
10 ug 
25 ug 
10 ug 
2ug 
10 ug 
30 ug 
25 ug 
10 ug 
10 ug 
10 ug 
10 ug 
30 ug 
30 ug 
30 ug 
10 ug 
5 ug 
100 ug 
30 ug 
50 ug 
60 ug 
30 ug 
10 ug 
5 ug incubation at 30°C 
5 ug 
2.7. SELECTION OF ANTIMICROBIALS FOR ROUTINE TESTING 
The agents are chosen according to: 
• Availability from hospital pharmacy. 
• Appropriateness for therapeutic use. 
The appropriate ring containing the discs required was carefully placed onto the 
inoculated plate. The discs were on the edge of the circle where the control and test 
organisms were adjacent to one another. 
As soon as possible and not later than 15 minutes after inoculation of plates, the 
antibiotic discs were applied so that diffusion and growth proceeded simultaneously. 
Once the discs were placed on the agar surface, they were not removed, since initial 
contact of the disc to the agar surface would immediately result in the diffusion 
process. These plates were incubated within 15 minutes at 35°C overnight. 
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Figure 2.2. DST agar plate showing control organism on the outside, test organism on 
the inside. A = resistant B = sensitive. 
2.8. INTERPRETATION OF RESULTS 
Zones of inhibition of the test organism were compared with those of the control. A 
millimetre rule was used for accuracy. Provided the inoculum was optimal, the results 
were reported as follows:- Sensitive: Zone radius equal, or wider than the control. 
Intermediate: Zone radius smaller than the control by up to 3=. Resistant: Zone 
radius more than 3= smaller than control (Figure 2.2.). This interpretation is not 
valid for some tests with penicillinase producing Staphylococci (Stokes & Ridgeway, 
1987). 
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2.9. METIlICILLIN SUSCEPTIBILITY TESTING 
As methicillin resistant staphylococci often appear fully sensitive when tested in the 
normal way, a separate DST agar plate was used and incubated at 30°C. The control 
organism was spread with a swab over half of the agar place. The other half was 
divided into two and the quarters were inoculated with a test organism each. 
2.10. COMPUTER PROGRAM 
After sorting, the reports were ready for processing. Manual computation of such data 
is tedious and subject to error, and analysis is ideally performed by a computer (Chan 
et al., 1988). 
A computer program "Antibug" was written by Professor CEJ Botha (Rhodes 
University) to provide a broad data base including: Date, laboratory number, Ward, 
Specimen type, sex, organism name and susceptibility result. The program was 
written in dBASE III but ran independently off dBASE II and could be used in 
laboratories which were not computerised and have an IBM compatible PC with a 
hard drive. The program was later modified to provide easily interpretable printed 
reports containing various results specified by the user. 
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2.11. STATISTICAL METHODS 
Using the null hypothesis, a test for proportions using a statistic was applied. There 
is a 5% level of significance where the value is greater than 1,96. There is a 1% 
level of significance where the value is greater than 2,33. 
2.12. DRUG USAGE IN THE HOSPITAL 
Information regarding the usage of antimicrobial agents was obtained from the 
hospital pharmacy for the three year period. 
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CHAPTER 3 
3. RESULTS 
Antibiotic resistance was determined for a range of bacterial species from clinical 
specimens submitted to the S.A.I.M.R. Pathology Laboratory from PHPE. Over the 
three year period 1989-1991, 5580 patient records produced 9888 isolates with sensitivity 
results. Table 3.1. su=arises the total numbers of in-patients, patient records and 
isolates for this period. 
Table 3.1. The total numbers of in-patients, total patient records and total isolates 
with susceptibility results PHPE. 
Year 
1989 
1990 
1991 
Number of in· 
patients 
160467 
144342 
142170 
Number of Number of 
patient isolates 
records 
1303 3455 
2156 3215 
2121 3218 
The data was logged onto "Antibug" the computer program developed for recording and 
reporting the 40 sampling centres (wards), 95 organisms, 33 antibiotics and 36 types of 
clinical specimens. 
Thus early in the investigation decisions had to be made with regard to the inclusion or 
exclusion of the various figures and in what format the data would be reported. 
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Decisions that needed to be made were: 
• Whether all individual sampling centres were to be reported in the results. An 
early analysis of the results showed that the only significant differences occurred 
between the combined wards of the whole hospital on the one hand and the ICU 
on the other. This has been collaborated by other workers (Stratton, 1990; 
Liebowitz & Koornhof, 1990). 
• It was decided in 1990 that the Out-patients department (OPD) shonld be 
evaluated as a separate entity in order to demonstrate a possible nosocomial 
component. Therefore OPD records were logged accordingly for 1990 and 1991. 
However, the numbers of isolates recorded from OPD except in the case of urine 
specimens, were very low. Therefore the comparison between organisms showing 
significant patterns of increasing resistance from the whole hospital and ICU, and 
OPD was not considered feasible. 
• Given a dissimilar range of antibiotics used for urinary infections in comparison 
to other infections, it was decided to consider urine specimens separately from all 
other specimens. 
In the case of the number of isolates from urine specimens the numbers were sufficiently 
high to make a comparison for OPD and the whole hospital to demonstrate a possible 
nosocomial component. 
42 
Antibiotic resistance patterns are considered below for the aforementioned organisms 
isolated. They were selected according to the frequency of isolation in the hospital, and 
the fact that they are cited as the most co=on nosocomial pathogens in the literature 
(Crowley et al., 1986; Smith et al., 1989). 
3.1. GRAM POSITIVE COCCI 
The 1989 figures for staphylococci presented below include the methicil1in resistant 
strains. It was decided in 1990 that it would be interesting to review the methicil1in 
sensitive and resistant isolates separately and compare the results. Therefore the figures 
for 1990 and 1991 reflect methicillin resistant and methicillin sensitive isolates separately. 
3.1.1. STAPHYLOCOCCUS AUREUS 
The annual resistance patterns of S. aureus from PHPE to a range of antibiotics is 
presented for the period, 1989 to 1991 for the whole hospital (Figure 3.1.) and the ICU 
(Figure 3.2.). Figures 3.3. and 3.4. report the mean of percentage resistance for isolates 
of methicillin sensitive S. aureus and Table 3.2. presents a comparison of percentage 
resistance between the whole hospital and the ICU over 1990 and 1991. 
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The annual resistance patterns for methicillin resistant S. aureus are presented for the 
whole hospital (Figure 3.5.) and the leU (Figure 3.6.) over the period 1990 and 1991. 
In 1990 and 1991, 67 and 88 isolates were recorded for the whole hospital and 15 and 
27 for the leU respectively. Figures 3.7. and 3.8. report the mean of percentage 
resistance for isolates of methicillin resistant S. aureus and Table 3.3. presents a 
comparison of percentage resistance between the whole hospital and the leU over the 
two year period. 
A statistical evaluation of the changing patterns of resistance of staphylococcal isolates 
(MSSA, MSSE, MRSA, MRSE) for the whole hospital and the leu is reported in 
Tables 3.4. and 3.5., respectively. 
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Figure 3.1. Percentage of isolates of MSSA from PHPE (whole 
hospital) showing resistance to a range of antibiotics over the 
three year period 1989-1991. 
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Figure 3.2. Percentage of isolates of MSSA from PHPE (leU) 
showing resistance to a range of antibiotics over the three year 
period 1989-1991. 
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Figure 3.3. The mean of resistant isolates of MSSA for PHPE 
(whole hospital). Resnlts reported with one standard deviation. 
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Figure 3.4. The mean of resistant isolates of MSSA for PHPE 
(ICU). Results reported with one standard deviation. 
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Figure 3.5. Percentage of isolates of MRSA from PHPE (whole 
hospital) showing resistance to a range of antibiotics over the 
two year period 1990-1991. 
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Figure 3.6. Percentage of isolates of MRSA from PHPE (leU) 
showing resistance to a range of antibiotics over the two year 
period 1990-1991. 
47 
~ RESI8~T.~~~N~C~e=-______________________________ -, 
100 -
°pl!/APCDI. TI!T !!RY COT ~uc eLI al!!N TOB IMI 0,..1. CIP 
Figure 3.7. The mean of resistant isolates of MRSA for PHPE 
(whole hospital). Results reported with one standard deviation. 
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Figure 3.8. The mean of resistant isolates of MRSA for PHPE 
(leU). Results reported with one standard deviation. 
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In 1989 the MRSA isolates were included in the analysis, resulting in the peaks in each 
instance, except for fucidin. The resistant isolates occurred in a lower percentage in 
the leu than the whole hospital except for clindamycin, gentamicin and tobramycin 
(Table 3.2.). Over 80% of the isolates showed resistance to penicillin/ampicillin while 
in all other instances the percentage resistance was below 13%. 
The decrease in the percentage resistance of methicillin sensitive S. aureus isolates from 
the whole hospital, to cefamandole, erythromycin, clindamycin and the aminoglycosides 
tested, was statistically significant (fable 3.4.). 
In 1989, 1990 and 1991 the percentage of methicillin resistant strains was 22%; 29% and 
29% respectively (Table 3.9.). In both the whole hospital and the leu the number of 
methicillin resistant S. aureus isolates was found to increase over each year. 
MRSA isolates showed a higher percentage resistance in the leu generally, particularly 
to cotrimoxazole and aminoglycosides in 1990 and to erythromycin, clindamycin and 
imipenem in 1991 (Table 3.3. and Figures 3.5. and 3.6.). 
The incidence of resistance was below 10% of the whole hospital isolates only in the case 
of fucidin, imipenem and the quinolones, and of the leu isolates only in the case of 
fucidin and the quinolones. The trend of increasing resistance in the whole hospital to 
cotrimoxazole and imipenem was found to be statistically significant and in the case of 
the leu only imipenem proved to a statistically significant increase. 
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Table 3.2. Comparison of percentage resistant isolates of S. aureus (MSSA) between 
the whole hospital and the ICU over the period 1990 and 1991. 
1990 1991 
Antibiotic Hosp ICU Hosp lCU 
PE/AP 88 84 90 95 
CDL 5 4 0 0 
TET 12 0 9 5 
ERY 12 0 6 5 
COT 9 0 5 5 
FUC 3 0 2 0 
CL1 5 4 1 5 
GEN 9 4 2 5 
TOB 9 4 2 5 
IMI NT 0 NT 0 
OFL NT 0 NT 0 
CIP NT 0 NT 0 
PIP 0 0 0 0 
VAN 0 0 0 0 
NT = not tested. 
Table 3.3. Comparison of percentage resistant isolates of methicillin resistant 
S. aureus (MRSA) between the whole hospital and the ICU over the 
period 1990 and 1991. 
1990 1991 
Antibiotic Hosp lCU Hosp ICU 
PEiAP 100 100 100 100 
CDL 100 100 100 100 
TET 82 80 89 93 
ERY 81 73 80 93 
COT 75 87 90 96 
FUC 4 13 9 8 
Cll 30 26 27 41 
GEN 78 93 89 96 
TOB 78 93 88 93 
IMI 0 0 7 22 
OFL 0 0 1 0 
CIP 0 0 1 0 
PIP 0 0 0 0 
VAN 0 0 0 0 
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Table 3.4. Test for proportions comparing percentage resistance of staphylococcal 
* 
** 
# 
isolates in PHPE (whole hospital) over the period 1990/1991. 
Antibiotic MSSA MSSE 
PE/AP 0,6113 # 1,0585 
CDL 2,9380 •• 2,6784 
TET 0,9338 # 1,1425 
ERY 1,9877 • 1,1498 
COT 1,4861 # 0,8120 
FUC 0,6082 # 0,2293 
Cll 2,1804 • 1,1107 
GEN 2,8763 •• 0,3773 
TOB 2,8763 •• 0,7104 
IMI 0 # 
° OFL 0 # 0 
CIP 0 # 0 
= 5% level of significance 
= 1% level of significance 
= above 5% level of significance 
MRSA MRSE 
# 0 # 0 
•• 0 # 0 
# 1,2157 # 3,8043 
# 0,1559 # 0,1822 
# 2,4266 •• 0 
# 1,2894 # 1,8623 
# 0,4092 # 0,1565 
# 1,8149 # 0,5672 
# 1,6306 # 1,4510 
# 2,5736 •• 0,6938 
# 0,9428 # 0,6344 
# 0,9428 # 1,5972 
# 
# 
•• 
# 
# 
# 
# 
# 
# 
# 
# 
# 
Table 3.5. Test for proportions comparing percentage resistance of staphylococcal 
* 
** 
# 
isolates in PHPE (leU) over the period 1990/1991. 
Antibiotic MSSA MSSE 
PE/AP 1,2587 # 1,4114 
CDL 1,0206 # 1,0719 
TET 1,0513 # 0,4913 
ERY 1,0513 # 0,1782 
COT 1,0513 # 0,5367 
FUC 0 # 0,6207 
Cll 0,1623 # 1,1450 
GEN 0,1623 # 0,5129 
TOB 0,1623 # 0,8386 
IMI 0 # 0 
OFL 0 # 0 
CIP 0 # 0 
= 5% level of significance 
1 % level of significance 
= above 5% level of significance 
MRSA 
# 0 # 
# 0 # 
# 1,1368 # 
# 1,6038 # 
# 0,9507 # 
# 0,4935 # 
# 1,0163 # 
# 0,2561 # 
# 0 # 
# 2,7596 •• 
# 0 # 
# 0 # 
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MRSE 
0 # 
° 
# 
3,1786 •• 
0,1350 # 
° 
# 
0,5066 # 
0,9854 # 
1,0495 # 
0 # 
2,0071 • 
1,5000 # 
1,5000 # 
3.1.2. STAPHYLOCOCCUS EPIDERMIDIS 
The percentage of resistant isolates of S. epidermidis from PHPE to a range of antibiotics 
is presented for the period 1989 to 1991. Figures 3.9. and 3.10. present results of annual 
resistance patterns and the mean of percentage resistance of methicillin sensitive S. 
epidermidis is reported in Figures 3.11. and 3.12. for the whole hospital and the leu 
respectively. Table 3.6. presents a comparison of percentage resistance between the 
whole hospital and leu over 1990 and 1991. 
The results of annual resistance patterns of methicillin resistant S. epidermidis are 
presented for the whole hospital (Figure 3.13.) and the leu (Figure 3.14.) over the 
period 1990 and 1991. In 1990 and 1991, 108 and 125 isolates were recorded for the 
whole hosital and 56 and 54 for the leU, respectively. Figures 3.15. and 3.16. report the 
mean of percentage resistance for isolates of methicillin resistant S. epidermidis and 
Table 3.7. presents a comparison of percentage resistance between the whole hospital 
and the leu over the two year period. 
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Figure 3.9. Percentage of isolates of MSSE from PHPE (whole 
hospital) showing resistance to a range of antibiotics over the 
three year period 1989-1991. 
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Figure 3.10. Percentage of isolates of MSSE from PHPE (leU) 
showing resistance to a range of antibiotics over the three year 
period 1989-1991. 
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Figure 3.11. The mean of resistant isolates of MSSE for PHPE 
(whole hospital). Results reported with one standard deviation. 
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Figure 3.12. The mean of resistant isolates of MSSE for PHPE 
(ICU). Results reported with one standard deviation. 
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Figure 3.13. Percentage of isolates of MRSE from PHPE (whole 
hospital) showing resistance to a range of antibiotics over the 
two year period 1990-1991. 
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Figure 3.14. Percentage of isolates of MRSE from PHPE (leU) 
showing resistance to a range of antibiotics over the two year 
period 1990-1991. 
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Figure 3.15. The mean of resistant isolates of MRSE for PHPE 
(whole hospital). Results reported with one standard deviation. 
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Figure 3.16. The mean of resistant isolates of MRSE for PHPE 
(leU). Results reported with one standard deviation. 
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The peaks in 1989 (Figures 3.9. and 3.10.) reflect the inclusion of the methicillin resistant 
isolates. In the leU penicillin/ampicillin, erythromycin, clindamycin and the 
aminoglycosides showed a higher percentage resistance than the whole hospital 
(Figures 3.11. and 3.12.). The decrease in percent resistance to cefamandole in the 
whole hospital was statistically significant (Table 3.4.). 
Table 3.8. presents the mean of percentage resistance of staphylococcal isolates (MSSA, 
MSSE, MRSA, MRSE) for the whole hospital. 
In 1989,1990 and 1991, the percentage ofmethiciIIin resistant strains was 43%,47% and 
47% respectively (Table 3.9.). In the whole hospital the number of isolates of 
methicillin resistant S. epidennidis was found to increase and that from the leU to 
marginally decrease. 
Only in the cases of fucidin, imipenem and the quinolones was the resistance below 40 
percent. Over 60% of isolates showed resistance to erythromycin, cotrimoxazole, 
cJindamycin and the aminogIycosides. 
The change in percentage resistance to tetracycline proved to be statistically significant 
in isolates from both the whole hospital and the leU and to imipenem in the leU only 
(Figures 3.13. and 3.14. and Tables 3.4. and 3.4.). 
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The mean of percentage resistance over 1990 and 1991 of staphylococcal isolates shows 
that S. epidermidis is more resistant than S. aureus except to penicillin/ampicillin in the 
methicillin sensitive isolates and tetracycline, erythromycin and gentamicin in the 
methicillin resistant isolates (Table 3.8.) . 
Table 3.10. presents a comparison of the percentage resistance and intermediate 
susceptibility to the newer agents tested for against staphylococci. The intermediate 
strains increased from 1990 to 1991 except for S. aureus and in 1991, the percentage of 
isolates showing intermediate susceptibility is higher than the resistance figure to each 
agent against MRSA, MRSE and S. epidermidis. 
Table 3.6. Comparison of percentage resistant isolates of S. epidermidis (MSSE) 
between the whole hospital and the ICU over the period 1990 and 1991. 
1990 1991 
Antibiotic Hosp ICU Hosp ICU 
PE/AP 80 78 85 94 
CDL 8 6 1 a 
TET 40 33 47 41 
ERY 38 44 45 47 
COT 53 50 58 59 
FUC 14 6 15 12 
Cll 18 27 13 12 
GEN 25 27 23 35 
TOB 31 39 27 53 
JMI 1 a a a 
OFL a a a a 
CIP a a a 
PIP a a a a 
VAN a a a a 
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Table 3.7. Comparison of percentage resistant isolates of methicillin resistant 
S. epidermidis (MRSE) between the whole hospital and the leu over the 
period 1990 and 1991. 
1990 1991 
Antibiotic Hosp ICU Hosp ICU 
PE/AP 100 100 100 100 
CDL 100 100 100 100 
TET 46 34 70 63 
ERY 77 82 78 81 
COT 90 93 90 93 
FUC 17 20 27 24 
Cll 62 80 61 72 
GEN 81 82 78 89 
TOB 87 90 80 90 
IMI 11 20 14 37 
OFL 1 0 2 4 
CIP 0 0 2 4 
PIP 0 0 0 0 
VAN 0 0 0 0 
Table 3.8. Average percentage resistance of staphylococci 1990/1991. 
Antibiotic MRSA MRSE MSSA MSSE 
PE/AP 100 100 90 83 
CDL 100 100 3 4 
TEl' 86 58 11 44 
ERY 81 78 9 42 
COT 83 90 7 56 
FUC 7 22 3 15 
Cll 29 62 3 16 
GEN 84 80 6 24 
TOB 83 84 6 29 
IMI 3,5 13 0 0.5 
OFL 0,5 1,5 0 0 
VAN 0 0 0 0 
MET 29 47 0 0 
CIP 0,5 1 0 0 
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Table 3.9. 
Table 3.10. 
Comparison of percentage methicillin resistance of MRSA and MRSE 
isolates over the period 1989 to 1991. 
Organism 
MRSA 
MRSE 
1989 
22 
43 
1990 
29 
47 
1991 
29 
47 
Comparison of percent resistant and intermediate strains of staphylococcal 
isolates to newer agents. 
1990 1991 
Organism Antibiotic R I R I 
MRSA IMl 0 4 7 13 
OFL 0 0 1 5 
elP 0 0 1 8 
MRSE 1M! 11 6 14 21 
OFL 1 0 2 8 
elP 0 0 2 8 
s. aureus IMI 0 0 0 0 
OFL 0 0 0 0 
elP 0 0 0 0 
s. epidermidis IMI 1 0 0 2 
OFL 0 0 0 1 
elP 0 0 0 1 
R = Resistant 
I = Intermediate 
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3.1.3. ENTEROCOCCUS FAECALIS 
The percentage of resistant isolates of E. faecalis from PHPE to a range of antibiotics 
is presented for the study period 1989 to 1991. 
Figures 3.17. and 3.18. present results of annual resistance patterns for the whole hospital 
and leu. In 1989,1990 and 1991, 115, 86 and 94 isolates ofE. faecalis were recorded 
for the whole hospital and 23, 13 and 23 for leu respectively. Figures 3.19. and 3.20. 
report the mean of percentage resistance for isolates over the period 1989 to 1991 and 
Table 3.11. presents a comparison of percentage resistance between the whole hospital 
and the ICU. 
A statistical evaluation of the changing patterns of resistance for the whole hospital and 
leu is reported in Tables 3.12. and 3.13., respectively. 
Over 60% of isolates showed resistance to penicillin and tetracycline for the whole 
hospital and to penicillin for ICU. Only in the case of ampicillin and piperacillin was 
the resistance below 10% of isolates. In the comparison of percentage resistance 
between the whole hospital and the ICU, tetracycline and erythromycin showed a lower 
resistance in the ICU than that recorded for the whole hospital (Table 3.11.). 
The increasing change of percent resistant of E. faecalis isolates from the whole hospital 
and leu to penicillin and to cotrimoxazole (whole hospital) proved to be statistically 
significant (Table 3.12., 3.13.). 
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Figure 3.17. Percentage of isolates of E. faecalis from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.18. Percentage of isolates of E. faecalis from PHPE 
(leU) showing resistance to a range of antibiotics over the three 
year period 1989-1991. 
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Figure 3.19. The mean of resistant isolates of E. faecalis for 
PHPE (whole hospital). Resnlts reported with one standard 
deviation. 
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Figure 3.20. The mean of resistant isolates of E. faecalis for 
PHPE (lCU). Results reported with one standard deviation. 
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Table 3.11. Comparison of percentage resistant isolates of E. faecalis between the 
whole hospital and ICU 1989/1991. 
1989 1990 1991 
Antibiotic Hosp lCU Hosp leu Hosp lCU 
AMP 7 9 2 0 4 4 
PIP 2 9 0 0 1 0 
PEN 35 35 66 77 91 91 
TET 71 57 74 62 63 48 
COT 24 30 51 54 51 43 
ERY 31 26 47 15 36 17 
IMI NT NT 0 0 3 13 
NT = not tested. 
Table 3.12. Test for proportions comparing % resistance of E. faecalis isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
• 
•• 
# 
Antibiotic 1989/1990 
AMP 1,7744 # 
PIP 1,5320 # 
PEN 4,5769 •• 
TET 0,4727 # 
COT 4,0285 •• 
ERY 2,3199 # 
= 5% level of significance 
= 1 % level of significance 
= above 5% level of significance 
1990/1991 1989/1991 
0,7928 # 0,9610 # 
0,9744 # 0,6022 # 
4,2375 •• 10,4906 •• 
1,6016 # 1,2242 # 
0 # 4,1442 •• 
1,5042 # 0,7615 # 
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Table 3.13. Test for proportions comparing % resistance of E. faecalis isolates in 
PHPE (leU) over the periods 1989/1990, 1990/1991 and 1989/1991. 
• 
** 
# 
Antibiotic 1989/1990 
AMP 1,5082 # 
PIP 1,5082 # 
PEN 2,7389 •• 
TET 0,2947 # 
COT 1,4282 # 
ERY 0,8160 # 
= 5% level of significance 
= 1 % level of significance 
= above 5% level of significance 
1990/1991 1989/1991 
0,9789 # 0,6914 # 
° 
# 1,5082 # 
1,0680 # 4,8283 •• 
0,8225 # 0,6137 # 
0,6376 # 0,9242 # 
0,1584 # 0,7474 # 
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3.1.4. ENTEROCOCCUS FAEClUM 
The percentage of resistant isolates of E. faecium from PHPE to a range of six antibiotics 
is presented for the study period 1989 to 1991. 
Figure 3.21. presents results of annual resistance patterns for the whole hospital. In 
1989, 1990 and 1991, 14, 15 and 15 isolates of E. faecium were recorded. 
Figure 3.22 reports the mean of percentage resistance and Table 3.14. presents a 
statistical evaluation of changing patterns of resistance for the whole hospital. E. 
faecium isolates from the leu were in 1989 two, 1990, three and 1991, six and too few 
to present annual resistance and compare with the whole hospital. 
Over 40% of isolates showed resistance to penicillin and tetracycline and only in the case 
of ampicillin, cotrimoxazole and piperacillin was the resistance 20% or below of isolates. 
The comparison of the change in resistance patterns over the three year period was 
made and it was found that resistance of E. faecium isolates from the whole hospital to 
penicillin showed a statistically significant increase. 
Table 3.15. presents a comparison of percent resistance for each year of the study period 
of E. faecalis and E. faecium and their respective mean resistance percentages. The 
mean percentage resistance of E. faecium is lower than E. faecalis except in the case of 
ampicillin and piperacillin. 
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Figure 3.21. Percentage of isolates of E. faecium from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.22. The mean of resistant isolates of E. faecium for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Table 3.14. Test for proportions comparing % resistance of E. faecium isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
• 
*. 
# 
Antibiotic 1989/1990 
AMP 0,0666 # 
PIP 0,5434 # 
PEN 0,6049 # 
TET 0,2166 # 
COT 1,4995 # 
ERY 0,2331 # 
= 5% level of significance 
= 1 % level of significance 
- above 5% level of significance 
1990/1991 1989/1991 
0 # 0,0666 # 
0 # 0,5434 # 
2,5741 •• 3,2922 •• 
0 # 0 # 
0 # 1,4995 # 
0,3593 # 0,1199 # 
Table 3.15. A comparison of percent resistance of E. faecalis and E. faecium isolates 
in PHPE (whole hospital) for 1989, 1990, 1991 and the mean percentage 
of the three years. 
1989 1990 1991 MEAN 
Alltlhlolk EJ'aecaUs E.t.aedam E.rateilU. E.h.edam E.IIIecaU. EJ'aedam E.laecaU. EJaedam 
PEN 35 36 66 47 91 87 64 57 
AMP 7 21 2 20 4 20 4 20 
TET 71 43 74 47 63 47 69 46 
ERY 31 29 47 33 36 27 38 30 
COT 24 7 51 27 51 27 42 20 
PIP 2 7 0 13 1 13 2 11 
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3.2. GRAM NEGATIVE BACILLI 
3.2.1. ACINETOBACTERANITRATUS 
The percentage of resistant isolates of A . anitratus from PHPE to a range · of fourteen 
antibiotics is presented for the study period 1989-1991. Figures 3.23. and 3.24. present 
results of annual resistance patterns for the whole hospital and for the ICU In 1989, 
1990 and 1991, 63, 58 and 49 isolates ofA. anitratus were recorded for the whole hospital 
and 42, 32 and 33 for ICU respectively. 
Figures 3.25. and 3.26. report the mean of percentage resistance for isolates over the 
period 1989-1991 and Table 3.16 presents a comparison of percentage resistance between 
the whole hospital and the ICU 
Tables 3.17. and 3.18. reports a statistical evaluation of changing patterns of resistance 
for the whole hospital and ICU respectively and Figure 3.27. shows this change in terms 
of a monthly percentage resistance pattern. 
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Figure 3.23 Percentage of isolates of A. aniJratus from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.24. Percentage of isolates of A. aniJratus from PHPE 
(leU) showing resistance to a range of antibiotics over the three 
year period 1989-1991. 
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Figure 3.25. The mean of resistant isolates of A. anitratus for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Figure 3.26. The mean of resistant isolates ofA. anitratus from 
PHPE (lCU). Results reported with one standard deviation. 
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Figure 3.27. Monthly percentage of resistant isolates over the 
three year period for PHPE (whole hospital) for A . anitraoo 
demonstrating a statistically siguificant change in pattern to 
ampicillin, amikacin and ceftazidime. 
In both the whole hospital and the ICU the number of isolates was found to decrease 
over each year of the study (Figures 3.23. and 3.24.). The results for the whole hospital 
and ICU show similar trends, but with resistant isolates occurring in a higher percentage 
of isolates in the ICU 
Over 80% of isolates showed resistance to a penicillin (AMP), second generation 
cephalosporins (CDL and FOX) and tetracycline. Only in the case of amikacin and 
imipenem was the resistance below 30% of isolates. However, the trend of increasing 
resistance to amikacin over the three year period was found to be a statistically 
significant change. In addition to the above trends, in the ICU over 80% of isolates 
showed resistance to gentamicin. 
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In the comparison of percentage resistance between the whole hospital and the lCU, the 
lCU percentage resistance is higher than that recorded for the whole hospital. The 
exceptions being: 
1989 - Cefoxitin 
1990 - Cotrimoxazole 
1991 - PiperaciIlin and cefoxitin 
The comparison of the change in resistance patterns over the three year period was made 
to determine whether any increase or decrease in percent resistance was statistically 
significant and it was found that resistance ofA. anitratus isolates from the whole hospital 
to ampicillin has shown a statistically significant decrease and to amikacin and 
ceftazidime a statistically significant increase. In the case of the lCU gentamicin, 
amikacin and ceftazidime showed a pattern of increasing resistance and cefoxitin both 
an increase (1989 to 1990) and a decrease (1990 to 1991). 
Where statistically significant changes were identified the monthly trends were plotted 
for the whole hospital in order to demonstrate the interval at which the particular change 
could have been identified for purposes of feedback to the clinical staff. 
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Table 3.16. Comparison of percentage Resistant isolates of A. anitratus between the 
whole hospital and leu 1989 - 1991. 
1989 1990 1991 
Antibiotic Hosp leu Hosp leu Hosp leu 
AMP 97 98 93 100 84 91 
PIP 44 52 50 56 41 39 
eDL 97 100 95 100 90 94 
TET 76 79 83 84 73 84 
eOT 65 74 66 59 61 64 
GEN 59 64 69 84 61 70 
TOB 46 55 57 59 63 64 
AMI 14 14 22 28 31 36 
FOX 79 74 91 100 78 76 
TAX 48 57 45 50 49 52 
IMI 10 12 7 13 12 24 
TAZ 2 2 31 31 39 39 
OFL NT NT NT 0 2 3 
eIP NT NT NT 0 0 0 
NT = not tested 
Table 3.17. Test for proportions comparing % resistance of A. anitTatus isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989{1990 1990{1991 1989/1991 
AMP 1,0049 # 1,4476 # 2,2964 • 
PIP 0,6617 # 0,9359 # 0,3189 # 
CDL 0,5588 # 0,9702 # 1,4600 # 
TET 0,9590 # 1,2446 # 0,3607 # 
eOT 0,1156 # 0,5353 # 0,4347 # 
GEN 1,1526 # 0,8655 # 0,2144 # 
TOB 1,2171 # 0,6331 # 1,8225 # 
AMI 1,1464 # 1,0516 # 2,1458 • 
FOX 1,8867 # 1,8545 # 0,1277 # 
TAX 0,3307 # 0,4137 # 0,1050 # 
IMI 0,5940 # 0,8734 # 0,3341 # 
TAZ 4,5858 •• 0,8655 # 5,1477 •• 
OFL NT 0 # 0 # 
eIP NT 0 # 0 # 
* = 5% level of significance 
** = 1% level of significance 
# = above 5% level of significance 
NT = not tested 
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Table 3.18. Test for proportions comparing % resistance of A. anitratus isolates in 
• 
•• 
# 
NT 
PHPE ICU over the periods 1989/1990, 1990/1991 and 1989/1991. 
Antibiotic 1989/1990 
AMP 0,9258 # 
PIP 0,3425 # 
CDL 0 # 
TET 0,5538 # 
COT 1,3614 # 
GEN 2,0322 • 
TOB 0,3449 # 
AMI 1,4622 # 
FOX 3,8415 •• 
TAX 0,5992 # 
IMI 0,1286 # 
TAZ 3,4294 •• 
OFL NT 
CIP NT 
= 5% level of significance 
= 1 % level of significance 
= above 5% level of significance 
= not tested 
1990/1991 1989/1991 
1,7225 # 1,2381 # 
1,3923 # 1,1336 # 
1,4513 # 1,4513 # 
0 # 0,5582 # 
0,4146 # 0,9300 # 
1,3621 # 0,5512 # 
0,4050 # 0,7725 # 
0,6942 # 2,2169 • 
3,2282 •• 0,1989 # 
0,1613 # 0,4319 # 
1,1556 # 1,3382 # 
0,6787 # 4,2232 •• 
0 # 0 # 
0 # 0 # 
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3.2.2. ENTEROBACTER CLOACAE 
The percentage of resistant isolates of E. cloacae from PHPE to a range of antibiotics 
is presented for the three year study period, 1989 - 1991. 
Figures 3.28. and 3.29. present results of annual resistance patterns for the whole hospital 
and for the lCU. In 1989, 1990 and 1991, 65, 51 and 64 isolates of E. cloacae were 
recorded for the whole hospital and 40, 34 and 36 for the ICU respectively. 
Figures 3.30. and 3.31. report the mean of percentage resistance for isolates from PHPE 
whole hospital and ICU respectively and Table 3.19. presents a comparison of percentage 
resistance between the whole hospital and the ICU. 
Tables 3.20. and 3.21. present a statistical evaluation of changing patterns of resistance 
for the whole hospital and ICU respectively and Figure 3.32. shows this change for the 
whole hospital in terms of a monthly percentage resistance pattern. 
The results for the whole hospital and ICU show similar trends with the exceptions in 
the case of piperacillin and cefamandole where the percentage resistant isolates showed 
an increase from 1989 to 1990, but decreased slightly in 1991 for the whole hospital, 
whereas in ICU they continued to increase. Over 90% of isolates showed resistance to 
ampicillin and cefoxitin and over 40% to tetracyclines. 
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Figure 3.28. Percentage of isolates of E. cloacae from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.29. Percentage of isolates of E. cloacae from PHPE 
(leU) showing resistance to a range of antibiotics over the three 
year period 1989-1991. 
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Figure 3.30 The mean of resistant isolates of E. cloacae for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Figure 3.31. The mean of resistant isolates of E. cloacae for 
PHPE (leU). Results reported with one standard deviation. 
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Figure 3.32. Monthly percentage of resistant isolates over the 
three year period for PHPE (whole hospital) for E. cloacae 
demonstrating a statistically significant change in pattern to 
piperacillin, cotrimoxazole and ceftazidime. 
In the comparison of percentage resistance between the whole hospital and the lCU 
(fable 3.19.) the leU percentage resistance is higher in the second and third generation 
cephalosporins and in 1991 for piperacillin. Ampicillin shows a higher percentage 
resistance in the whole hospital. 
The comparison of the change in resistance patterns over the study period showed that 
increases in percent resistance of E. cloacae to ampicillin, piperacillin, tetracycline, 
cotrimoxazole, cefoxitin, cefotazime and ceftazidime for the whole hospital, were 
statistically significant. The decrease is in resistance to cefoxitin for the period 1990 to 
1991 was noted and was found to be statistically significant. 
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In the case of the ICU, ampicillin, piperacillin, tetracycline, cotrimoxazole, cefotazime 
and ceftazidime all showed a pattern of statistically significant increasing resistance. 
The statistically significant changes were identified as mainly occurring in piperacillin, 
cotrimoxazole and ceftazidime and monthly trends were plotted for the whole hospital 
in order to attempt to demonstrate an interval at which the occurrence of the particular 
change could be determined (Figure 3.32.). 
Table 3.19. Comparison of percentage resistant isolates of E. cloacae between the 
whole hospital and ICU over the three year period 1989 - 1991. 
1989 1990 1991 
Antibiotic Hosp ICU Hosp ICU Hosp lCU 
AMP 89 82 98 97 95 92 
PIP 3 3 18 18 17 28 
CDL 20 25 27 29 23 39 
TET 28 30 51 53 41 36 
COT 9 8 16 15 36 33 
GEN 5 8 4 3 3 3 
TOB 5 8 4 3 3 3 
AMI 0 0 0 0 2 3 
FOX 94 98 100 100 92 92 
TAX 3 5 14 18 22 36 
TAZ 0 0 12 15 22 36 
IMI 8 13 2 3 3 3 
OFL NT NT NT 0 0 0 
CIP NT NT NT NT 0 0 
NT = not tested 
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Table 3.20. Test for proportions comparing % resistance of E. cloacae isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1999/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 2,0699 • 0,8938 # 1,2654 # 
PIP 2,5948 •• 0,1400 # 2,7184 •• 
CDL 0,8801 # 0,4912 # 0,4149 # 
TET 2,5712 •• 1,0733 # 1,5671 # 
COT 1,1216 # 2,5328 •• 3,8729 •• 
GEN 0,2596 # 0,2878 # 0,5809 # 
TOB 0,2596 # 0,2878 # 0,5809 # 
AMI 
° 
# 1,1429 # 1,1429 # 
FOX 2,0368 • 2,3591 •• 0,4452 # 
TAX 2,0757 • 1,1266 # 3,3967 •• 
IMI 1,5407 # 0,3452 # 1,2551 # 
TAZ 2,6522 •• 0,9725 # 4,2487 •• 
OFL NT 
° 
# 
° 
# 
CIP NT 
° 
# 
° 
# 
* = 5% level of significance 
*. = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
Table 3.21. Test for proportions comparing % resistance of E. cloacae isolates in 
PHPE (leU) over the periods 1989/1990, 1990/1991 and 1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 2,2248 • 0,9284 # 1,3205 # 
PIP 2,1069 • 1,0029 # 3,1428 •• 
CDL 0,3859 # 0,8886 # 1,3173 # 
TET 2,0509 • 1,4510 # 0,5559 # 
COT 0,9363 # 1,8098 # 2,7983 •• 
GEN 0,9629 # 
° 
# 0,9716 # 
TOB 0,9629 # 
° 
# 0,9716 # 
AMI 
° 
# 1,0552 # 1,0552 # 
FOX 0,9035 # 1,7693 # 1,1918 # 
TAX 1,7484 # 1,7368 # 3,5589 •• 
IMI 1,6477 # 
° 
# 1,6584 # 
TAZ 2,4495 •• 2,0844 • 4,5000 •• 
OFL NT 
° 
# 
° 
# 
CIP NT 
° 
# 
° 
# 
• = 5% level of significance 
*. = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
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3.2.3. ESCHERICHIA COLl 
The percentage of resistant isolates of E. coli from PHPE to a range of antibiotics is 
presented for the study period 1989 - 1991. 
Figures 3.33. and 3.34. present results of annual resistance patterns for the whole hospital 
and for the ICU. In 1989, 1990 and 1991, 103, 117 and 132 isolates of E. coli were 
recorded for the whole hospital and 22, 24 and 33 for the ICU respectively. 
Figures 3.35. and 3.36. report the mean of percentage resistance for isolates over the 
period 1989 - 1991 and Table 3.22. presents a comparison of percentage resistance 
between the whole hospital and ICU. Tables 3.23. and 3.24. report a statistical 
evaluation of changing patterns of resistance for the whole hospital and ICU respectively. 
The number of isolates was found to increase over each year of the study in both the 
whole hospital and the ICU (Figures 3.33. and 3.34.). The results for the whole hospital 
and lCU both showed three peaks in percentage resistance to ampicillin, tetracycline and 
cotrimoxazole with over 60% of isolates showing resistance to ampicillin and 
cotrimoxazole. Except for piperaciIIin, the resistance to all other agents was below 20 
percent of isolates. In both the whole hospital and ICU the resistance of isolates to 
piperaciIIin and cefoxitin peaked in 1990. 
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Figure 3.33. Percentage of isolates of E. coli from PHPE (whole 
hospital) showing resistance to a range of antibiotics over the 
three year period 1989-1991. 
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Figure 3.34. Percentage of isolates of E. coli from PHPE (lCU) 
showing resistance to a range of antibiotics over the three year 
period 1989- 1991. 
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Figure 3.35. The mean of resistaqnt isolates ofE. coli for PHPE 
(whole hospital). Results reported with one standard deviation. 
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Figure 3.36. The mean of resistant isolates of E. coli for PHPE 
(leU). Results reported with one standard deviation. 
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Table 3.22. Comparison of percentage resistant isolates of E. coli between the whole 
hospital and ICU over the three year period 1989 - 1991. 
1989 1990 1991 
Antibiotic Hosp leu Hosp leu Hosp leu 
AMP 77 64 77 67 73 79 
PIP 13 14 23 25 8 18 
eDL 8 14 5 17 1 3 
TET 57 45 55 42 58 60 
eOT 53 45 68 58 70 70 
GEN 4 9 3 4 1 3 
TOB 4 14 3 4 2 3 
AMI 1 5 1 4 2 0 
FOX 3 5 6 13 4 3 
TAX 1 5 1 4 1 3 
TAZ 0 0 2 4 0 0 
IMI a a 1 4 1 3 
OFL NT NT NT 0 1 3 
elP NT NT NT NT 0 a 
NT = not tested 
In the comparison of percentage resistance between the whole hospital and the ICU 
(Table 3.22.), the ICU percentage resistance is higher than that recorded for the whole 
hospital. The exceptions being ampicillin, tetracycline and cotrimoxazole in 1989 and 
1990, and amikacin in 1991. 
The statistically significant changes in resistance patterns were compared for the three 
year study period and identified for the whole hospital (fable 3.23.). Piperacillin 
showed both an increase in percentage resistance (1989 - 1990) and a decrease (1990 -
1991). Cefamandole demonstrated a decrease and cotrimoxazole, an increase in 
percentage resistance over the three years. In the ICU, none of the changes proved to 
be statistically significant (fable 3.24.). 
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Table 3.23. Test for proportions comparing % resistance of E. coli isolates in PHPE 
(whole hospital) over the periods 1989/1990, 1990/1991 and 1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 0 # 0,7294 # 0,7057 # 
PIP 1,9568 • 3,2959 •• 1,2288 # 
CDL 0,8962 # 1,8239 # 2,4912 •• 
TET 0,2983 # 0,4767 # 0,1538 # 
COT 2,2933 • 0,3404 # 2,6848 •• 
GEN 0,4011 # 1,1116 # 1,4177 # 
TOB 0,4011 # 1,1116 # 1,4177 # 
AMI 0 # 0,6550 # 0,6394 # 
FOX 1,0850 # 0,7194 # 0,4176 # 
TAX 0 # 0 # 0 # 
IMI 1,0871 # 0 # 1,1547 # 
TAZ 1,5452 # 1,5452 # 0 # 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
Table 3.24. Test for proportions comparing % resistance of E. coli isolates in PHPE 
(leU) over the periods 1989/1990, 1990/1991 and 1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 0,2138 # 1,0056 # 1,2048 # 
PIP 0,9544 # 0,6315 # 0,4011 # 
CDL 0,2816 # 1,7026 # 1,3799 # 
TET 0,2051 # 1,3637 # 1,1021 # 
COT 0,8887 # 0,9338 # 1,8837 # 
GEN 0,6853 # 0,2007 # 0,8842 # 
TOB 1,1890 # 0,2007 # 1,3799 # 
AMI 0,1631 # 1,000 # 1,0761 # 
FOX 0,9651 # 1,3370 # 0,3627 # 
TAX 0,1631 # 0,2007 # 0,3627 # 
IMI 1,000 # 0,2007 # 1,0103 # 
TAZ 1,000 # 1,000 # 0 # 
OFL NT 0 # 0 # 
CIP NT 0 # 0 # 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
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3.2.3.1. ESCHERICHIA COLI ISOLATES FROM URINE SPECIMENS 
Figures 3.37. and 3.38. present results of annual resistance patterns for the whole hospital 
for the period 1989 to 1991 and for OPD for 1990 and 1991. 
The number of isolates of E. coli recorded from both the whole hospital and OPD was 
found to decrease over each year of the study. Results for the whole hospital and OPD 
show similar trends but with resistant isolates occurring in a higher percentage of isolates 
in the whole hospital. 
Over 60% of isolates showed resistance to ampicillin, cotrimoxazole and sulphonamides 
and in the case of nalidixic acid, nitrofurantoin and nicene, the resistance was below 12% 
of isolates. 
In the comparison of percentage resistance between the whole hospital and OPD, the 
whole hospital percentage resistance is higher or equal to in all instances than that 
recorded for OPD (Table 3.25.). 
The comparison of the change in resistance patterns was made to determine whether any 
increase or decrease in percent resistance was statistically significant and it was found 
that resistance of E. coli isolates from the whole hospital to cotrimoxazole and 
sulphonamides showed a statistically significant increase and to Nicene, a statistically 
significant decrease (Table 3.26.). Table 3.27. reports a statistical evaluation for OPD 
and shows that the changes were not significant. 
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Figure 3.37. Percentage of isolates from urine specimens of 
E. coli from PHPE (whole hospital) showing resistance to a 
range of antibiotics over the three year period 189·1991. 
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Figure 3.38. Percentage of isolates from urine specimens of 
E. coli from PHPE (OPD) showing resistance to a range of 
antibiotics over the two year period 1990·1991. 
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Table 3.25. Comparison of percentage resistant isolates of E. coli between the whole 
hospital and OPD over the three year period 1989-1991. 
1989 1990 1991 
Antibiotic Hosp Hosp OPD Hosp OPD 
AMP 74 77 60 73 65 
COT 68 80 62 80 71 
SUL 82 90 82 90 90 
NAL 10 7 8 9 3 
NIT 9 8 3 11 8 
mc 3 2 2 0 0 
Table 3.26. Test for proportions comparing % resistance of E. coli (urine) isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 0,9502 # 1,0156 # 0,2750 # 
COT 3,8178 •• 0 # 3,4695 •• 
SUL 3,2497 •• 0 # 2,9749 •• 
NAL 1,4909 # 0,8063 # 0,4190 # 
NIT 0,4890 # 1,1174 # 0,7970 # 
mc 0,8912 # 2,4286 •• 3,9363 •• 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
Table 3.27. Test for proportions comparing % resistance of E. coli (urine) isolates in 
PHPE (OPD) over the period 1990/1991. 
Antibiotic 1990/1991 
AMP 0,6949 # 
COT 1,1525 # 
SUL 1,6031 # 
NAL 1,5635 # 
NIT 1,4048 # 
mc 1,5584 # 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
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3.2.4. KLEBSIELLA AEROGENES 
The percentage of resistant isolates of K aerogenes from PHPE to a range of fourteen 
antibiotics is presented for the three year period 1989 to 1991. 
Figures 3.39. and 3.40. present results of annual resistance patterns for the whole hospital 
and for the leu. . In 1989, 1990 and 1991, 88, 57 and 69 isolates of K aerogenes were 
recorded for the whole hospital and 32, 27 and 35 for leu respectively. Figures 3.41. 
and 3.42. report the mean of percentage resistance for isolates over the period 1989 -
1991 and Table 3.28. presents a comparison of percentage resistance between the whole 
hospital and the lCU. Tables 3.29 and 3.30. present the statistical evaluations of 
changing patterns of resistance for the whole hospital and leu respectively. 
The results for the whole hospital and leu show similar trends with an exception being 
found in cotrimoxazole where in 1989 the percentage resistance was 57% in the whole 
hospital and 41% in lCU. (Figures 3.39. and 3.40.). Over 90% of isolates showed 
resistance to ampicillin and 50% and over to tetracycline and cotrimoxazole for the 
whole hospital and leu. A percentage resistance for K aerogenes isolates of between 
28 and 30 percent is reported for the whole hospital and leu to gentamicin and 
tobramycin (Figures 3.41. and 3.42.). 
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Figure 3.39. Percentage of isolates of K. aerogenes from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.40. Percentage of isolates of K. aerogenes from PHPE 
(leU) showing resistance to a range of antibiotics over the three 
year period 1989-1991. 
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Figure 3.41. The mean of resistant isolates of K aerogenes for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Figure 3.42. The mean of resistant isolates of K aerogenes for 
PHPE (lCU). Results reported with one standard deviation. 
92 
In the comparison of percentage resistance between the whole hospital and the ICU 
(fable 3.28.) the ICU percentage resistance is lower than that recorded for the whole 
hospital in the majority of instances; where it is hlgher, it is only marginally so. 
The comparison of the change in resistance patterns over the three year period was made 
to determine whether any increase or decrease in percent resistance was statistically 
significant and it was found that resistance of K aerogenes isolates from the whole 
hospital to ampicillin, piperacillin, gentamicin and tobramycin have shown a statistically 
significant decrease and an increase in tetracycline (1989 to 1990). In the case of the 
lCU, ampicillin, gentamicin and tobramycin showed a pattern of decreasing resistance 
and cotrimoxazole an increase 1989 to 1990 and 1989 to 1991 that were all statistically 
significant. 
Table 3.28. Comparison of percentage resistant isolates of K aerogenes between the 
whole hospital and ICU over the three year period 1989-1991. 
1989 1990 1991 
Antibiotic Hosp leU Hosp leu Hosp leu 
AMP 100 100 93 89 88 86 
PIP 42 34 40 33 23 23 
eDL 20 19 21 19 10 11 
TET 43 41 61 63 49 46 
eOT 57 41 70 70 67 66 
GEN 39 41 35 30 16 14 
TOB 39 41 33 30 16 14 
AMI 0 0 0 0 0 0 
FOX 5 9 5 4 4 6 
TAX 1 3 2 4 0 0 
TAZ 0 0 0 0 1 0 
IMI 0 0 0 0 0 0 
OFL NT NT NT 0 0 0 
eIP NT NT NT NT 0 0 
NT = not tested 
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Table 3.29. Test for proportions comparing % resistance of K aerogenes isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 2,0713 • 0,9672 # 3,0674 •• 
PIP 0,2394 # 2,0650 • 2,6013 •• 
CDL 0,1454 # 1,6943 # 1,7896 # 
TET 2,1578 • 1,3591 # 0,7496 # 
COT 1,6163 # 0,3615 # 1,2921 # 
GEN 0,4889 # 2,4654 •• 3,3724 •• 
TOB 0,7395 # 2,2271 • 3,3724 •• 
AMI 0 # 0 # 
° 
# 
FOX 0 # 0,2682 # 0,3020 # 
TAX 0,4681 # 1,0785 # 0,9428 # 
IMI 
° 
# 0 # 
° 
# 
TAZ 
° 
# 0,8348 # 0,8348 # 
OFL NT 0 # 0 # 
CIP NT 0 # 0 # 
• = 5% level of significance 
•• = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
Table 3.30. Test for proportions comparing % resistance of K aerogenes isolates in 
PHPE (leU) over the periods 1989/1990, 1990/1991 and 1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 1,3268 # 0.3569 # 2,3870 •• 
PIP 0,0814 # 0,8688 # 1,001 # 
CDL 0 # 0,8678 # 0,9173 # 
TET 1,7289 # 1,3554 # 0,4130 # 
COT 2,3417 •• 0,3358 # 2,1151 • 
GEN 0,8882 # 1,5107 # 2,5744 •• 
TOB 0,8882 # 1,5107 # 2,5744 •• 
AMI 0 # 0 # 0 # 
FOX 0,7924 # 0,3631 # 0,4645 # 
TAX 0,2071 # 1,0607 # 0,9948 # 
IMI 0 # 0 # 0 # 
TAZ 0 # 0 # 
° 
# 
OFL NT 0 # 0 # 
CIP NT 0 # 0 # 
• = 5% level of significance 
•• = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
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3.2.5. PROTEUS MlRABILIS 
The percentage of resistant isolates of P. mirabilis from PHPE to a range of antibiotics 
is presented for the three year study period, 1989 to 1991. 
Figures 3.43. and 3.44. present results of annual resistance patterns for the whole hospital 
and the leu. In 1989, 1990 and 1991, 170, 134 and 147 isolates of P. mirabilis were 
recorded for the whole hospital and 47, 37 and 42 for the lCU respectively. 
Figures 3.45. and 3.46. report the mean of percentage resistance for isolates from PHPE, 
whole hospital and leU respectively and Table 3.31. presents a comparison of percentage 
resistance between the whole hospital and the leu. Tables 3.32. and 3.33. report a 
statistical evaluation of changing patterns of resistance for the whole hospital and leu 
respectively. 
The results for the whole hospital and leU both showed two peaks in percentage 
resistance to ampicillin and cotrimoxazole with the lCU isolates being 16 and 12 percent 
lower respectively than for the whole hospital. In the leU the trend of decreasing 
resistance to cotrimoxazole over the three year period was found to be a statistically 
significant change. The resistance to all other agents was below 14 percent of isolates 
for both the whole hospital and the leu. 
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Figure 3.43. Percentage of isolates of P. mirabilis from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989·1991. 
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Figure 3.44. Percentage of isoaltes of P. mirabilis from PHPE 
(leU) showing resistance to a range of antibiotics over the three 
year period 1989·1991. 
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Figure 3.45. The mean of resistant isolates of P. mirabilis for 
PHPE (whole hospital). Results reported with one standard 
deviation . 
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Figure 3.46. The mean of resistant isolates of P. mirabilis for 
PHPE (leU). Results reported with one standard deviation. 
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Table 3.31. Comparison of percentage resistant isolates of P. mirabilis between the 
whole hospital and ICU over the three year period 1989-1991. 
1989 1990 1991 
Antibiotic Hosp ICU Hosp lCU Hosp lCU 
AMP 48 19 49 41 42 29 
PIP 4 0 10 8 5 7 
CDL 5 9 6 8 3 0 
TET 100 100 100 100 100 100 
COT 42 38 40 30 39 17 
GEN 3 6 12 18 6 2 
TOB 4 6 8 5 3 0 
AMI 0 0 1 3 1 0 
FOX 2 2 4 11 1 2 
TAX 0 0 2 5 1 0 
TAZ 0 0 0 3 0 0 
IMI 2 6 1 8 2 7 
OFL NT NT NT 0 0 0 
CIP NT NT NT NT 0 0 
NT = not tested 
In the comparison between the whole hospital and the ICU, the majority of percentage 
resistance was lower in the ICU especially ampicillin and cotrimoxazole. However, in 
the case of imipenem, the ICU percentage resistance was higher (Table 3.31.). 
The comparison of the change in resistance patterns over the study period showed that 
increases in percent resistance ofP. mirabilis to piperacillin and gentamicin for the whole 
hospital were statistically significant. In the ICU, ampicillin showed an increase (1989 
to 1990) and cefamandole and cotrimoxazole a decrease (1989 to 1991) of statistical 
significance. 
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Table 3.32. Test for proportions comparing % resistance of P. mirabilis isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 0,1732 # 1,1795 # 1,0732 ## 
PIP 2,0028 • 1,5853 # 0,4268 # 
CDL 0,3779 # 1,2059 # 0,9158 # 
TET 0 # 0 # 0 # 
COT 0,3522 # 0,1713 # 0,5431 # 
GEN 2,9059 •• 1,7528 # 1,2736 # 
TOB 1,4367 # 1,8291 # 0,4857 # 
AMI 1,1634 # 0 # 1,2185 # 
FOX 0,9977 # 1,5947 # 0,7399 # 
TAX 1,6537 # 1,6537 # 0 # 
IMI 0,7271 # 0,6947 # 0 # 
TAZ 0 # 0 # 0 # 
OFL NT 0 # 0 # 
CIP NT 0 # 0 # 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
Table 3.33. Test for proportions comparing % resistance of P. mirabilis isolates in 
PHPE (leU) over the periods 1989/1990, 1990/1991 and 1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 2,2209 • 1,1219 # 1,1059 # 
PIP 1,7937 # 0,1681 # 1,7780 # 
CDL 0,1637 # 1,7937 # 2,1560 • 
COT 0,7738 # 1,3676 # 2,2951 • 
GEN 0,3542 # 1,2107 # 0,9798 # 
TOB 0,2007 # 1,3955 # 1,7321 # 
AMI 1,0697 # 1,0697 # 0 # 
FOX 1,6262 # 1,6132 # 0 # 
TAX 1,3955 # 1,3955 # 0 # 
IMI 0,3542 # 0,1681 # 0,1907 # 
TAZ 1,0697 # 1,0697 # 0 # 
OFL NT # 0 # 0 # 
CIP NT # 0 # 0 # 
* = 5 % level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
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3.2.5.1. PROTEUS MIRABILIS ISOLATES FROM URINE SPECIMENS 
Figures 3.47. and 3.48. present results of annual resistance patterns for the whole hospital 
for the period 1989 to 1991 and for OPD for 1990 and 1991. 
The number of isolates of P. mirabilis recorded from both the whole hospital and OPD 
was found to decrease over the study period. In 1989, 1990 and 1991, 77, 58 and 38 
isolates were recorded from the whole hospital and in 1990 and 1991, 14 and 6 from 
OPD respectively. 
Only in the case of nalidixic acid and nicene was the percentage resistance below 22% 
and 5% respectively. In the comparison of percentage resistance between the whole 
hospital and OPD, the results recorded were very similar for 1990. However, in 1991, 
the OPD isolates showed a higher percentage resistance than the whole hospital to 
ampicillin, cotrimoxazole and sulphonamides. (fable 3.34.) 
Tables 3.35. and 3.36. present a statistical evaluation of the change in resistance patterns. 
The increases in percent resistance to nitrofuratoin for the whole hospital and to 
cotrimoxazole for OPD proved to be statistically significant. 
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Figure 3.47. Percentage of isolates from urine specimens of 
P. mirabiJis from PHPE (whole hospital) showing resistance to 
a range of antibiotics over the three year period 1989-1991. 
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Figure 3.48. Percentage of isolates from urine specimens for 
P. mirabiJis from PHPE (OPD) showing resistance to a range of 
antibiotics over the two year period 1990-1991. 
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Table 3.34. Comparison of percentage resistant (urine) isolates ofP. mirabilis between 
the whole hospital and OPD over the three year period 1989-1991. 
1989 1990 1991 
Antibiotic Hosp Hosp OPD Hosp OPD 
AMP 66 60 57 61 83 
COT 66 60 57 68 100 
SUL 74 74 79 84 100 
NAL 10 17 14 21 0 
NIT 92 98 100 100 100 
NIC 0 0 0 3 0 
Table 3.35. Test for proportions comparing % resistance of P. mirabilis (urine) 
isolates in PHPE (whole hospital) over the periods 1989/1990, 1990/1991 
and 1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 0,7145 # 0,0981 # 0,5220 # 
COT 0,7145 # 0,8055 # 0,2152 # 
SUL 0 # 1,2079 # 1,2872 # 
NAL 1,1664 # 0,4851 # 1,4786 # 
NIT 1,6681 # 1,0880 # 2,5876 •• 
NIC 0 # 1,0841 # 1,0841 # 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
Table 3.36. Test for proportions comparing % resistance of P. mirabilis (urine) 
isolates in PHPE (OPD) over the period 1990/1991. 
Antibiotic 1990/1991 
AMP 1,2837 # 
COT 3,2498 •• 
SUL 1,9291 # 
NAL 1,5097 # 
NIT 0 # 
NIC 0 # 
* = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
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3.2.6. PSEUDOMONAS AERUGINOSA 
The percentage of resistant isolates of P. aeruginosa from PHPE to a range of eight 
antibiotics is presented for the study period 1989 to 1991. 
Figures 3.49. and 3.50. report results of annual resistance patterns for the whole hospital 
and leu. In 1989, 1990 and 1991, 176, 134 and 150 isolates of P. aeruginosa were 
recorded for the whole hospital and 70, 68 and 77 for leu respectively. Figures 3.51. 
and 3.52. present the mean of percentage resistance for isolates over the period 1989 -
1991 and Table 3.37. reports a comparison of percentage resistance between the whole 
hospital and the leu. Tables 3.38. and 3.39. report a statistical evaluation of changing 
patterns of resistance for the whole hospital and leu. 
In the whole hospital P. aeruginosa isolates showed percentage resistance of 10 percent 
and under to all antibiotics tested except for imipenem which peaked in 1990 to 18 
percent. The increase of resistance 1989 to 1990 was found to be a statistically 
significant change. This peak is also found in the lCU with imipenem but at almost 
double the percentage resistance. Ciprofloxacin and ofloxacin, tested against this 
organism only in 1991, were recorded as 5 and 7 percent resistance respectively for the 
whole hospital and 6 and 12 percent resistance respectively for the leu. 
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Figure 3.49. Percentage of isolates of P. aernginosa from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.50. Percentage of isolates of P. aernginosa from PHPE 
(leU) showing resistance to a range of antibiotics over the three 
year period 1989-1991. 
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Figure 3.51. The mean of resistant isolates of P. aeruginosa for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Figure 3.52. The mean of resistant isolates of P. aeruginosa for 
PHPE (leU). Results reported with one standard deviation. 
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Table 3.37. Comparison of percentage resistant isolates of P aeruginosa between the 
whole hospital and ICU over the three year period 1989-1991. 
* 
NT 
1989 
Antibiotic Hosp ICU 
PIP 0 0 
GEN 5 9 
TOB 5 9 
AMI 1 1 
TAZ 1 1 
IMI 4 10 
OFL NT NT 
CIP NT NT 
= Tested in fourth quarter only. 
= Not tested 
1990 1991 
Hosp ICU Hosp ICU 
2 4 3 4 
10 7 3 5 
10 7 3 5 
4 3 3 4 
1 3 4 6 
18 35 13 23 
NT O· 7 12 
NT NT 5 6 
In the comparison between the whole hospital and lCU, the percentage resistance of 
lCU is higher than that recorded for the whole hospital except for the aminoglycosides 
which showed a decrease in 1990. 
The comparison of the change in resistance patterns over the three year period was made 
to determine whether any increase or decrease in percent resistance was statistically 
significant and it was found that resistance of P. aeruginosa isolates from the whole 
hospital to piperacillin and imipenem have shown a statistically significant increase and 
to gentamicin a statisticaIly significant decrease. In the case of the lCU imipenem, 
ofloxacin and ciprofloxacin showed an increase in resistance that was statisticaIly 
significant (Tables 3.38. and 3.39.). 
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Table 3.38. Test for proportions comparing % resistance of P. aeruginosa isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
* 
** 
# 
NT 
Antibiotic 1989{1990 
PIP 1,6537 # 
GEN 1,6295 # 
TOB 1,6295 # 
AMI 1,6203 # 
IMI 3,8539 •• 
TAZ 0 # 
OFL NT 
CIP NT 
= 5% level of significance 
= 1% level of significance 
= above 5% level of significance 
= not tested 
1990/1991 1989/1991 
0,5421 # 2,1539 • 
2,3792 •• 0,9286 # 
2,3792 •• 0,9286 # 
0,4562 # 1,2643 # 
1,1608 # 2,8865 •• 
1,6517 # 1,6977 # 
3,3601 •• 3,3601 •• 
2,8098 •• 2,8098 •• 
Table 3.39. Test for proportions comparing % resistance of P. aeruginosa isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989{1990 1990{1991 1989/1991 
PIP 1,6832 # 0 # 1,7912 # 
GEN 0,4336 # 0,5041 # 0,9463 # 
TOB 0,4336 # 0,5041 # 0,9463 # 
AMI 0,8382 # 0,3285 # 1,1857 # 
IMI 3,6736 •• 1,5971 # 2,1710 • 
TAZ 0,8382 # 0,8807 # 1,6914 # 
OFL NT 3,2404 •• 3,2404 •• 
ClP NT 2,2170 • 2,2170 • 
• = 5% level of significance 
** = 1 % level of significance 
# = above 5% level of significance 
NT = not tested 
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Figure 3.53. Percentage of isolates from urine specimens of 
P. aeruginosa from PHPE (whole hospital) showing resistance to 
a range of antibiotics over the three year period 1989-1991. 
3.2.6.1. PSEUDOMONAS AERUGINOSA ISOLATES FROM URINE SPECIMENS 
Figures 3.53. presents results of annual resistance patterns for the whole hospital for the 
study period, 1989 to 1991. The number of isolates recorded from the whole hospital 
for 1989, 1990 and 1991, were 62, 34 and 41 respectively. The number of isolates 
recorded from OPD were 9 in 1990 and 5 in 1991, with nil percent resistance. The 
percent resistance to all the antibiotics tested were 15% or below and no increase or 
decrease in resistance proved to be statistically significant. (Table 3.40.) No resistance 
was recorded to ceftazidinie. 
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Table 3.40. Test for proportions comparing % resistance of P. aeruginosa (urine) 
isolates in PHPE (whole hospital) over the periods 1989/1990, 1990/1991 
and 1989/1991. 
* 
** 
# 
NT 
Antibiotic 1989/1990 
PIP 0,2921 # 
GEN 0,6933 # 
TOB 0,2963 # 
AMI 0 # 
NOR NT 
IMI NT 
TAZ NT 
OFL NT 
CIP NT 
= 5% level of significance 
= 1 % level of significance 
= above 5% level of significance 
= not tested 
1990/1991 1989/1991 
1,0254 # 1,1249 # 
0,3772 # 0,3152 # 
0 # 0,3152 # 
1,4690 # 1,4690 # 
1,4690 # NT 
1,7567 # NT 
0 # NT 
1,4690 # NT 
0,9147 # NT 
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3.2.7. SERRATIA MARCESCENS 
The percentage of resistant isolates of S. marcescens from PHPE to a range of antibiotics 
is presented for the three year study period 1989 to 1991. 
Figure 3.54. presents results of annual resistance patterns for the whole hospital. In 
1989, 1990 and 1991, 36, 17 and 24 isolates of S. marcescens respectively were recorded. 
Figure 3.55. reports the mean of percentage resistance for isolates from PHPE and Table 
3.41. presents a statistical evaluation of changing patterns of resistance for the hospital. 
The results showed a pattern of increasing resistance to tetracycline and a decreasing 
resistance to cefoxitin. These trends over the three year period were found to be 
statistically significant changes (fable 3.41.). 
The numbers of isolates of S. marcescens recorded were too low in the ICU to report a 
comparison between the whole hospital and ICU. 
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Figure 3.54. Percentage of isolates of S. marcescens from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989·1991. 
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Figure 3.55. The mean of resistant isolates of S. marcescens for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Table 3.41. Test for proportions comparing % resistance of S. marcescens isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
* 
** 
# 
NT 
1989/1991. 
Antibiotic 1989/1990 
AMP 0,6394 # 
PIP 
° 
# 
CDL 0,8836 # 
TET 0,6394 # 
COT 1,2938 # 
GEN 0,4265 # 
TOB 0,6718 # 
AMI 
° 
# 
FOX 1,5340 # 
TAX 1,0404 # 
IMI 1,4947 # 
TAZ 1,0404 # 
OFL NT 
CIP NT 
= 5% level of significance 
= 1 % level of significance 
= above 5% level of significance 
= not tested 
1990/1991 
0,6830 
1,8937 
0,1331 
1,0417 
1,0978 
0,4320 
0,2402 
0,2852 
1,3806 
° 0 
0 
° 
° 
3.2.8. XANTHOMONAS MALTOPHILIA 
1989/1991 
# 0,1179 # 
# 1,8937 # 
# 0,8370 # 
# 2,0799 • 
# 0,0867 # 
# 1,0116 # 
# 0,4488 # 
# 0,3529 # 
# 3,6300 •• 
# 1,0404 # 
# 1,4947 # 
# 1,0404 # 
# 0 # 
# 
° 
# 
The percentage of resistant isolates of X maltophilia from PHPE to a range of eight 
antibiotics is presented for the study period 1989 to 1991. 
Figure 3.56. presents results of annual resistance patterns for the whole hospital. In 
1989, 1990 and 1991, 13, 12 and 16 isolates respectively, of X maltophilia were recorded. 
Figure 3.57. reports the mean of percentage resistance for isolates from PHPE and 
Table 3.42. presents a statistical evaluation of changing resistance patterns for the 
hospital. 
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Figure 3.56. Percentage of isolates of X TTUlltophilia from PHPE 
(whole hospital) showing resistance to a range of antibiotics 
over the three year period 1989-1991. 
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Figure 3.57. The mean of resistant isolates of X TTUlltophilia for 
PHPE (whole hospital). Results reported with one standard 
deviation. 
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Table 3.42. Test for proportions comparing % resistance of X maltophilia isolates in 
PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989/1990 
PIP 1,1652 # 
GEN 1,4084 # 
TOB 0,2001 # 
AMI 0,2041 # 
IMI 0,7077 # 
TAZ 3,4641 •• 
Started testing TAZ in 4th quarter 1989. 
* 
** 
# 
NT 
= 5% level of significance 
= 1 % level of significance 
= above 5% level of significance 
- not tested 
1990/1991 1989/1991 
0 # 1,2895 # 
0,5995 # 2,2004 • 
1,3856 # 1,1961 # 
1,8442 # 2,1419 • 
0,3524 # 0,3944 # 
1,3856 # 2,3094 • 
The results showed a trend of increasing resistance to piperacillin, gentamicin, 
tobramycin, amikacin and imipenem. Only in the case of piperacillin, ofioxacin and 
ciprofioxacin was the resistance below 20% of isolates. 
The comparison of the change in resistance patterns over the three year period was made 
to determine whether any increase or decrease in percent resistance was statistically 
significant and it was found that resistance of X maltophilia isolates to gentamicin and 
amikacin has shown a statistically significant increase and to ceftazidime a statistically 
significant decrease, 1990 to 1991. Ciprofioxacin and ofioxacin, tested against this 
organism in 1991, were recorded as 6 percent resistance for both for the whole hospital. 
The numbers of isolates of X maltophilia recorded were too low in the ICU to report 
a comparison between the whole hospital and ICU. 
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Table 3.43. Comparison of percent resistant and intermediate strains of Gram-negative 
bacilli to newer agents. 
1989 1990 1991 
Organism Antibiotic R I R I R I 
A. anitratos TAZ 0 2 31 34 39 22 
IMI 10 30 7 9 12 6 
OFL 0 0 2 22 
elP 0 22 
E. cloacae TAZ 0 2 12 0 22 2 
IM! 8 11 2 20 3 9 
OFL 0 0 0 5 
elP 0 5 
E. coli TAZ 0 1 2 0 0 1 
IM! 0 1 1 1 1 1 
OFL 0 0 1 1 
elP 0 2 
K. aerogenes TAZ 0 1 0 4 1 4 
IM! 0 6 0 0 0 4 
OFL 0 0 0 12 
elP 0 7 
P.mirabilis TAZ 0 0 0 1 0 0 
IM! 2 2 1 4 2 5 
OFL 0 0 0 6 
elP 0 1 
S. marcescens TAZ 3 0 0 0 0 0 
IMI 6 6 0 0 0 0 
OFL 0 0 0 0 
elP 0 4 
P. aeru.ginosa TAZ 1 0 1 2 4 5 
IM! 4 3 18 3 13 3 
OFL 0 0 7 3 
ClP 5 2 
X. maltopbilia TAZ 0 0 50 8 25 31 
IM! 62 6 75 0 69 0 
OFL 0 0 6 31 
elP ~ ~ 
- = not tested R = Resistant I = Intermediate 
Table 3.43. presents a comparison of the percentage resistance and intermediate 
susceptibility to the newer agents tested against the Gram-negative bacilli. Ofloxacin 
and ciprofloxacin show intermediate susceptibility to most of the organisms. 
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3.2.9. COLIFORM ISOLATES FROM URINE SPECIMENS 
This group of organisms consists of a variety of Gram negative bacilli excluding 
Pseudomonas species. They are not fully identified for reasons of cost and turn-around-
time, and include E. coli, Klebsiella species, Enterobacter species and Proteus species 
amongst others. 
Figures 3.58. and 3.59. present results of annual resistance patterns for the whole hospital 
for the period 1989 to 1991 and for OPD for 1990 and 1991. In 1989, 1990 and 1991, 
91, 55 and 127 Coliform isolates were recorded from the whole hospital and in 1990 and 
1991, 42 and 46 from OPD respectively. Over 60% of isolates showed resistance to 
ampicillin and cotrimoxazole and over 80% to sulphonamides in both the whole hospital 
and OPD. No resistance was found to nicene in OPD and nalidixic acid showed a 
percent resistance of below 20%. 
Table 3.44. reports a comparison of percentage resistance between the whole hospital 
and OPD. In 1990, OPD resistance figures were higher than the whole hospital except 
for nitrofurantoin. Whereas in 1991, the whole hospital resistance figures were higher 
than OPD except for sulphonamides which were similar. 
Tables 3.45. and 3.46. presents a statistical evaluation of changing patterns of resistance 
for the whole hospital and OPD respectively. It was found that resistance of Coliform 
isolates from the whole hospital to nitrofurantoin has shown a statistically significant 
increase and to nicene a significant decrease. 
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Figure 3.5S. Percentage of isolates from urine specimens of 
Coliforms from PHPE (whole hospital) showing resistance to a 
range of antibiotics over the three year period 1989-1991. 
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Figure 3.59. Percentage of isolates from urine specimens of 
Coliforms from PHPE (OPD) showing resistance to a range of 
antibiotics over the two year period 1990-1991. 
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Table 3.44. Comparison of percentage resistant isolates of Coliforms between the 
whole hospital and OPD over the three year period 1989-1991. 
1989 1990 1991 
Antibiotic Hosp Hosp OPD Hosp OPD 
AMP 78 76 79 84 61 
COT 69 76 81 78 72 
SUL 80 84 86 88 89 
NAL 16 15 26 17 11 
NIT 34 53 36 46 33 
NlC 9 0 0 2 0 
Table 3.45. Test for proportions comparing % resistance of Coliforms (urine) isolates 
in PHPE (whole hospital) over the periods 1989/1990, 1990/1991 and 
1989/1991. 
Antibiotic 1989/1990 1990/1991 1989/1991 
AMP 0,2773 # 1,2095 # 1,1058 # 
COT 0,9299 # 0,2927 # 1,4792 # 
SUL 0,6171 # 0,6989 # 1,5720 # 
NAC 0,1623 # 0,3415 # 0,1966 # 
NIT 2,2717 • 0,8692 # 1,8046 # 
NlC 3,000 •• 1,6099 # 2,1558 • 
* 5% level of significance 
*. = 1 % level of significance 
# = above 5% level of significance 
Table 3.46. Test for proportions comparing % resistance of Coliform (urine) isolates 
in PHPE (OPD) over the period, 1990/1991. 
Antibiotic 1990/1991 
AMP 1,8847 # 
COT 1,0033 # 
SUL 0,4245 # 
NAL 1,8313 # 
NIT 0,2957 # 
NlC 0 # 
* = 5% level of significance 
*. = 1 % level of significance 
# = above 5% level of significance 
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3.2.10. PATTERNS OF CHANGING RESISTANCE 
Increased resistance to certain antibiotics was found to occur in a number of organisms 
and certain organisms show changing patterns of resistance to a variety of antibiotics. 
Table 3.47. su=arises the evaluation of the statistically significant changes observed and 
was used to determine which antibiotics should be investigated more fully and which 
organisms would be of interest for comparing with OPD. It was decided that 
cotrimoxazole, amikacin, ampicillin, ceftazidime and piperacillin would be plotted against 
the organisms. The comparison with OPD isolates was not made as the numbers of 
isolates were too low for a statistically significant evaluation. 
It is evident that a number of organisms are showing increasing patterns of resistance to 
more than one antibiotic and in the case of E. cloacae, this multiple resistance is to four 
antibiotics. However, a decrease in resistance is also observed and in Klebsiella 
aerogenes, the significant changes are a decrease in resistance to four antibiotics. A 
second feature that emerges from the evaluation of changing resistance patterns over the 
period, is that resistance to a particular antibiotic is emerging simultaneously in more 
than one organism with cotrimoxazole and amikacin showing this pattern. 
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Table 3.47. Summary of change in resistance patterns showing statistically significant 
differences over the three year period. 
Total Total 
increase decrease 
A p C T C G T A F T T J of of 
II J D E 0 E 0 II 0 A A II resist- resist-
p p L T T N B J X X Z J anee of ance of 
organ- organ-
isms isms 
Ao anitratus 0 + + 2 1 
• • •• 
Eo cloacae + + + + 4 D 
•• •• •• 
-
Ko .. rogenes 0 0 0 0 0 4 
.. .. .. .. 
P. lIirabil is 0 0 
E .. coli 0 + 1 1 
• • 
S .. marcescens + 1 0 
• 
P. aeruginosa + 1 0 
-
X .. maltophil ia + + 0 2 1 
• • • 
TotaL increase 
of resistance 0 1 0 1 2 1 0 2 0 1 2 1 
of antibiotic 
Total decrease 
of resistance 2 1 1 0 0 1 1 0 0 0 1 0 
of antibiotic 
* = 5 % level of significance 
** = 1 % level of significance 
+ = increase in resistance 
= decrease in resistance 
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3.2.10.1. COMMON RESISTANCE PATTERNS 
Figures 3.60. - 3.69. represent the resistance pattern in a range of organisms to the 
following antibiotics: 
Cotrimoxazole 
Amikacin 
Ampicillin 
Ceftazidime 
Piperacillin 
E. cloacae and E. coli show a statistically significant increase in resistance to 
cotrimoxazole 1989 to 1991, as presented in Figure 3.60. Over 60% of A . anitratus, 
K aerogenes and E. coli are resistant to this antibiotic with P. mirabilis isolates showing 
a mean resistance of 40% (Figure 3.61; Tables 3.20. and 3.23.). 
X maltophilia is the most resistant of the eight organisms to amikacin with a mean of 
52%. A . anitratus isolates show a mean resistance of 22%. The increases in percent 
resistance 1989 to 1991, are statistically significant for these two organisms (Figures 3.62. 
and 3.63., Tables 3.42. and 3.17.). 
Ampicillin resistance was over 80% to all organisms reported except for E. coli and 
P. mirabilis which showed mean percentages of 75% and 45%, respectively (Figures 3.64. 
and 3.65.). The decreases in percent resistance againstA. anitratus and K aerogenes are 
statistically significant (Tables 3.17. and 3.29.). 
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The increases in percentage resistance to ceftazidime in A . anitratus, E. cloacae and 
X maltophilia isolates 1989 to 1991, are statistically significant with their mean 
percentage resistance as 35%, 17% and 25%, respectively (Figures 3.66. and 3.67., Tables 
3.20. and 3.42.). The other organisms show 5% and less, resistance to the antibiotic. 
Three peaks of mean resistance to piperacillin are evident in Figures 3.68. and 3.69., 
these beingA. anitratus, K aerogenes and X maltophilia. Statistically significant changes 
occurred as an increase in E. cloacae and a decrease in K aerogenes, 1989 to 1991 
(Tables 3.20. and 3.29.). The other six organisms showed 15% or less mean resistance 
to this antibiotic. 
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Figure 3.60. Percentage resistance to cotrimoxazole for PHPE 
(whole hospital) of six organisms over the three year period 
1989-1991. 
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Figure 3.61. The mean of resistance to cotrimoxazole for PHPE 
(whole hospital) of six organisms over the three year period 
1989-1991. 
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Figure 3.62. Percentage resistance to amikacin for PHPE (whole 
hospital) of eight organisms over the three year period 1989-
1991. 
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Figure 3.63. The mean of resistance of amikacin for PHPE 
(whole hospital) of eight organisms over the three year period 
1989-1991. 
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Figure 3.64. Percentage resistance to ampicillin for PHPE 
(whole hospital) of six organims over the three year period 
1989-1991. 
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Figure 3.65. The mean of resistance to ampicillin for PHPE 
(whole hospital of six organisms over the three year period 
1989-1991. 
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Figure 3.66. Percentage resistance to ceftazidime for PHPE 
(whole hospital) of eight organisms over the three year period 
1989-1991. 
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Figure 3.67. The mean of resistance to ceftazidime for PHPE 
(whole hospital) of eight organisms over the three year period 
1989·1991. 
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Figure 3.68. Percentage resistance to piperacillin for PHPE 
(whole hospital) of eight organisms over the three year period 
1989-1991. 
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Figure 3.69. The mean of resistance to piperacillin for PHPE 
(whole hospital) of eight organisms over the three year period 
1989-1991. 
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3.2.11. A COMPARATIVE SUMMARY OF ANTIBIOTIC RESISTANCE 
Antibiotic surveillance reports supplied by Bristol-Myers Squibb (Pty) Limited were 
collated from four hospitals in South Africa: Universitas Hospital, Bloemfontein; 
Hillbrow Hospital, Johannesburg; Groote Schuur Hospital and Red Cross Childrens' 
Hospital, Cape Town. 
The data from Universitas and Hillbrow Hospitals was for the whole year (1991) while 
the data from Groote Schuur and Red Cross Hospitals was for nine months of 1991. 
The program is in the development phase and not all data was being picked up resulting 
in inaccuracies. However, this is the only source of this type of information and 
permission to use it was granted by the Chairman of the Antibiotic Study Group of 
South Africa, Professor P Botha. 
Table 3.48. to 3.55. present a comparative summary of percentage resistance between 
PHPE and the aforementioned hospitals for eight organisms previously described. In 
Table 3.51. the other hospitals in South Africa call this organism Klebsiella pneumoniae. 
In the data from Red Cross Childrens' Hospital and to a lesser extent the others, certain 
antibiotics are not reported on. Universitas Hospital's data appeared to include urine 
isolates and the numbers of isolates from the Cape Town hospitals were few. However, 
it was decided to include all data collated as this was all that was available for 
comparison. 
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Table 3.48. Comparison of percentage resistance ofA. anitratus isolates in PHPE and 
other S.A. hospitals in 1991. 
Antibiotic Universitas 
AMP 81 
PIP 32 
CDL 100 
TET 70 
COT 47 
GEN 33 
TOB 
AMI 28 
FOX 100 
TAX 48 
TAZ 39 
IMI 12 
CIP 10 
OFL 0 
- = not reported 
Hillbrow GSH 
99 98 
81 33 
98 
96 
39 
83 79 
48 75 
74 5 
92 
78 88 
62 37 
3,5 16 
2 14 
30 
Red X P.E. 
96 84 
41 
90 
73 
26 61 
13 61 
63 
o 31 
78 
49 
39 
12 
o 
2 
Table 3.49. Comparison of percentage resistance of E. cloacae isolates in PHPE and 
other S.A. hospitals in 1991. 
Antibiotic Universitas GSH Red X P.E. 
AMP 93 89 50 95 
PIP 40 33 17 
CDL 34 35 23 
TET 58 41 
COT 39 9 47 36 
GEN 17,7 3 16 3 
TOB 3,7 3 3 
AMI 0,4 0 0 2 
FOX 79 74 92 
TAX 32 22 
TAZ 32 29 22 
IMI 0 3 
eIP 1 0 0 
OFL 0 0 0 
- = not reported 
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Table 3.50. Comparison of percentage resistance ofE. coli isolates in PHPE and other 
S.A. hospitals in 1991. 
Antibiotic Universitas 
AMP 72 
PIP 22 
CDL 7 
TEl' 65 
COT 59 
GEN 2 
TOB 2 
AMI 15 
FOX 11 
TAX 2 
TAZ 5 
IMI 0,5 
CIP 0 
OFL 0 
- = not reported 
Hillbrow GSH 
65 57 
31 23 
14 
66 72 
50 
2,5 3 
1,5 3 
1 1 
0.5 
1 1 
1 5 
0 
0.5 1 
1 
Red X P.E. 
73 73 
8 
1 
58 
63 73 
2,5 1 
2 
0,5 2 
4 
1 
o 
1 
o 
1 
Table 3.51. Comparison of percentage resistance of K aerogenes isolates in PHPE and 
K pneumoniae in other S.A. hospitals in 1991. 
Antibiotic Universitas Hillbrow GSH Red X P.E. 
AMP 94 97 97 98 88 
PIP 28 21 23 
CDL 33 26 10 
TEl' 40 50 49 
COT 48 28 53 67 
GEN 9 13 16 35 16 
TOB 7 17 13 16 
AMI 1 4 0,5 1 0 
FOX 7 3 4 
TAX 12 9 20 0 
TAZ 8 10 50 25 1 
(4 Isolates) 
IMI 0 0 0 0 
( ....... ) 
CIP 0,5 2 1 0 
OFL 0,5 4 0 
- = not reported 
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Table 3.52. Comparison of percentage resistance of P. mirabilis isolates in PHPE and 
otber S.A. hospitals in 1991. 
Antibiotic Universitas Hillbrow GSH Red X P.E. 
AMP 42 24 29 50 42 
PIP 3 2 5 
(J iIoIatcI) 
CDL 0 10 3 
(2' """") 
TET 97 98 100 100 
COT 29 21 38 39 
GEN 2 2 5 7 6 
TOB 1 1 1 3 
AMI 05 0.5 0 0 1 
FOX 0 5 1 
TAX 1 05 0 0 
TAZ 0 05 0 0 
IMI 2 0 0 2 
CIP 0 0 0 0 
OFL 0 0 0 
- = not reported 
Table 3.53. Comparison of percentage resistance of S. marcescens isolates in PHPE 
and otber SA hospitals in 1991. 
Antibiotic Universitas Hillbrow GSH Red X P.E. 
AMP 97 97 91 100 88 
(11 hoWea) 
PIP 2 11 13 
CDL 29 67 33 
(3"""") 
TET 96 97 100 
COT 24 27 38 25 
(11 iIolate&) 
GEN 8 16 27 29 13 
(11 isollUel) 
TOB 11 16 21 
AMI 0 11 0 7 4 
FOX 7 0 4 
TAX 2 3 0 
TAZ 0 0 0 
IMI 5 0 0 
CIP 0 0 0 0 
OFL 0 0 
- = not reported 
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Table 3.54. Comparison of percentage resistance ofP. aerugiIWsa isolates in PHPE and 
other S.A. hospitals in 1991. 
Antibiotic Universitas HiJlbrow GSH Red X P.E. 
PIP 3,5 7 1,5 3 
GEN 25 20 20 11,5 3 
TOB 7 18 20 5,5 3 
AMI 1,5 6 0,5 3 3 
TAZ 8 8 1,5 3 4 
IMI 12,5 14 17 13 
CIP 0,7 2 8,5 0 5 
OFL 9 14,5 1 7 
- = not reported 
Table 3.55. Comparison of percentage resistance of X maltophilia isolates in PHPE 
and other S.A. hospitals in 1991. 
Antibiotic Universitas Red X P.E. 
PIP 34 25 
COT 39 67 
GEN 80 30 69 
TOB 74 32 75 
AMI 70 30 75 
TAZ 27 11 25 
IMI 100 100 69 
CIP 4 5 6 
OFL 0 6 
= not reported 
132 
3.3. ANTIBIOTIC USAGE 
A variety of twenty-four antibiotics were used in the hospital over the period 1989 - 1991. 
Information from the pharmacy was obtained as to the usage of these agents and the 
conversion factors for converting into dosage figures. Not all the dosage information 
was available because of package differences and the different forms of availability of 
some agents ego tablets, suspensions, ampules etc. 
Ward stock sheets were checked but this was found to be vel)' inaccurate according to 
ward and pharmacy staff, therefore gross monthly figures from pharmacy stock sheets 
were used. Only figures for nine months of 1990 were available and have been 
extrapolated for twelve months. Bearing the above facts in mind Table 3.56. presents 
a list of agents that were able to be converted into doses and their relevant doses for 
1990 and 1991. Analysis of the figures show that the drug usage pattern did not change 
significantly. Unfortunately there was not adequate data to correlate changing patterns 
of antibiotic usage with resistance changes, one of the most important aspects of this 
study. 
Ampicillin, penicillin, fucidin, tetracycline, erythromycin, clindamycin, vancomycin, 
nicene, nitrofuratoin and nalidixic acid were all included in the investigation. However, 
they were not all able to be converted into dose related figures as they are prepacked or 
tablets and suspensions. The co=ent made by the Chief Pharmacist was that the 
hospital uses a lot of second generation cephalosporins and arninoglycosides (Table 
3.56.). 
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Table 3.56. Number of doses per antibiotic over the period 1990 and 1991. 
Antibiotic 1990 1991 
PiperaciIIin 2600 2055 
Cefamandole 9467 10085 
Cotrimoxazole 433 255 
Gentamicin 4967 4756 
Tobramycin 4627 5850 
Netilmicin 2100 2270 
Amikacin 2947 2725 
Cefoxitin 27467 28000 
Cefotaxime 1120 1340 
Imipenem 300 780 
Ceftazidime 950 854 
CiproOoxacin 0 980 
OOoxacin 0 130 
Table 3.57. Time-table of the introduction of newer agents tested for in the laboratory 
and first used in the hospital. 
Agent 
TAZ 
IMI 
ClP 
OFL 
Laboratory Hospital 
27/10/89 Sept 1990 
(all Pseudomonas 
species 
SepI1990) 
27/10/89 Sept 1990 
leu only 
1991 1991 
leu only 
Oct 1990 1991 
leu only 
Table 3.57. reports the dates of introduction of the newer agents into the hospital and 
when testing started in the laboratory. The agents for lCU only were tested and 
reported on isolates from the rest of the hospital if the organism showed resistance to 
most or all of the routine antibiotics. 
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CHAPTER 4 
4. DISCUSSION 
Infections caused by resistant bacteria have been a fact of life ever since effective 
antibacterial drugs became available. While the percentage resistance of the clinical 
isolates evaluated in this study generally follows the trends observed in other centres in 
South Africa and other countries, there were some notable differences. 
4.1. STAPHYLOCOCCUS SPECIES 
The high incidence of drug resistance in 1989 observed with S. aureus and S. epidermidis 
(Figures 3.1., 3.2., 3.9. and 3.10.) are due to the inclusion of methicillin resistant strains 
in 1989 only. In 1990 and 1991, methicillin sensitive and resistant strains were separated 
to evaluate and compare the resistance patterns of each. MSSE isolates were 
considerably more resistant than MSSA particularly to tetracycline, erythromycin, 
cotrimoxazole, fusidic acid, clindamycin and gentamicin and tobramycin, the differences 
being statistically significant (Table 3.8.). 
With reference to the results presented in Table 3.8., MRSA isolates were found to be 
less resistant than MRSE stains except against the drugs tetracycline, erythromycin and 
gentamicin. Resistance to fusidic acid, clindamycin and imipenem was found to be 
significantly higher for MRSE isolates. 
135 
The methicillin resistant strains of S. aureus and S. epidermidis increased from 1989 to 
1990 and then remained static for 1991; 22% and 43% in 1989 and 29% and 47% in 
1990 and 1991 respectively (Table 3.9.). In a Nigerian hospital methicillin resistance to 
S. aureus was not found (Olusanya et aI., 1991), while in the N.N.I.S. report of 1984 
resistance to methicillin was 14% and 56%, respectively (Isenberg, 1988). 
There was a statistically significant decrease in percent resistance to cefamandole by both 
MSSA and MSSE isolates; this is not related to the agent's usage as this in fact 
increased slightly over the period as shown in Table 3.56. Resistance to vancomycin was 
not detected over the study period. 
The percent resistance of S. aureus isolates in this study for 1989 was higher or in the 
case of clindamycin equal to that given for 1987 in Durban and in the N.N.I.S. report of 
1984 (van den Ende, 1989; Isenberg, 1988). Findings in this study were: penicillin 89%; 
cefamandole 23%; tetracycline 26%; erythromycin 21 %; cotrimoxazole 18%; fusidic acid 
2%; clindamycin 11 %; gentamicin 19% and methicillin 22% (Figure 3.1. and Table 3.9.). 
The findings of this study concur with other workers that S. epidermidis is overall more 
resistant to antibiotics than S. aureus (Davies et aI., 1986; Eykyn, 1988; McGowan, 1988; 
van den Ende, 1989). 
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A comparison of percent resistant and intermediate strains of staphylococci to newer 
agents i.e., imipenem, ofioxacin and ciprofioxacin (fable 3.10.) shows that while in some 
instances the increase in resistance is minimal, there is a decrease in susceptibility to all 
of these agents when the intermediate results are compared for 1990 and 1991 from the 
whole hospital. 
In comparison with the findings of Daum et al., (1990) this study found an emergence 
of resistance to ciprofioxacin among MRSA but no resistance among S. aureus isolates. 
4.2. ENTEROCOCCUS SPECIES 
Our findings of a mean of 4 and 20 percent ampicillin resistance in E. faecalis and E. 
faecium isolates respectively is similar to the trends reported in the United Kingdom and 
the N.N.I.S. report (Gray et al., 1991; Isenberg, 1988). 
The increase of resistance to penicillin in both enterococcal species is statistically 
significant and ampicillin and piperacillin would appear to be agents of choice 
particularly in the case of E. faecalis . 
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4.3. ACINETOBACTER ANITRATUS 
A. anitratus proved to be the most resistant Gram -negative bacillus of this study showing 
a high percentage of resistance to ten of the fourteen agents reported. The quinolones, 
imipenem and amikacin appear to be the best choice of agent for treatment, in order of 
increasing resistance respectively. The mean gentamicin resistance of 63% for the whole 
hospital and of 73% for the ICU, is much higher than other studies (McGowan et al., 
1993; Moaz et al., 1989). Compared to other S.A. hospitalsA. anitratus in this study has 
a lower percent resistance than Hillbrow and Groote Schuur Hospitals and higher than 
Universitas Hospital (Table 3.48.). Monthly trends of statistically significant changes 
did not demonstrate any useful information or seasonal variance as shown in Figure 3.27. 
4.4. ENTEROBACTER CLOACAE 
The pattern of increasing resistance to cotrimoxazole, cefotaxime and ceftazidime among 
isolates of E. cloacae from the whole hospital, and including piperacillin among isolates 
from the lCU, is disturbing. John Jr et al., (1982) found that the newer agents e.g. 
cefazidime were active against E. cloacae while in this study in 1991 the percent 
resistance is over 20 percent to this agent (Table 3.19.). The aminoglycosides and the 
quinolones prove to be the agents of choice where this organism is implicated in 
infection. Except for tetracycline and cotrimoxazole E. cloacae has lower percent 
resistance figures than that of the N.N.I.S. report (Isenberg, 1988). 
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Compared to the other SA. hospitals, PHPE has lower resistance figures to most agents. 
The notable exceptions being amikacin and cefoxitin in all instances as shown in 
Table 3.49. 
Monthly trends showed two peaks for cotrimoxazole in May 1990 and 1991, two peaks 
for piperacillin in July and October 1990 and a peak for ceftazidime in July 1990. 
However, no meaningful information could be determined from this data (Figure 3.32.). 
4.5. ESCHERICHIA COll 
E. coli isolates from the PHPE are very susceptible to most agents in use, the exceptions 
being ampicillin (76%), tetracycline (57%) and cotrimoxazole (64%), with respective 
percent resistances given in brackets. In Figures 3.33. and 3.34. and Table 3.22. 
resistance to piperacillin peaked to 23% in 1990 in the whole hospital and 25% in ICU, 
otherwise the resistance was fairly low. The mean gentamicin resistance for the whole 
hospital, 3% and the ICU 5%, is higher than other studies i.e. 1,6% in Riyadh (Moaz 
et at., 1989) and 1% in the N.N.I.S. report (Isenberg, 1988). Compared to the other 
SA. hospitals, E. coli strains from PHPE are much more resistant to cotrimoxazole 
(Table 3.50.). 
E. coli isolates from urine. specimens were found to be highly resistant to ampicillin, 
cotrimoxazole and sulphonamides. Isolates from the out-patients were slightly less 
resistant but percent resistance of over 60% was shown. The urinary antimicrobials, 
nalidixic acid, nitrofurantoin and nicene showed a resistance of 11% and below. 
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4.6. KLEBSIELlA AEROGENES 
Amikacin, second and third generation cephalosporins, the quinolones and imipenem 
have a resistance rate of less than 20% for K aerogenes isolates. Over 50% of the 
isolates are resistant to ampicillin, tetracycline and cotrimoxazole with resistance of 97%, 
51 % and 65% respectively. Compared to the other S.A. hospitals, K aerogenes strains 
from PHPE are more resistant to tetracycline, cotrimoxazole, gentamicin and tobramycin 
(Table 3.51.). However, resistance to amikacin, and in particular cefotaxime and 
ceftazidime, is much lower. 
4.7. PROTEUS MIRABILIS 
P. mirabilis isolates from PHPE were found to be susceptible to most agents with the 
exceptions of ampicillin and cotrimoxazole showing between 40 and 50 percent 
resistance. The decrease in resistance in the ICU to cotrimoxazole and to a lesser 
degree to ampicillin (1990-1991) as shown in Figure 3.44. and Table 3.13, is encouraging 
and needs to be monitored to determine whether this trend will continue. The mean 
gentamicin resistance for the whole hospital, 7% and the lCU 9% is lower than those 
reported in other studies i.e. 15% in Riyadh (Moaz et ai., 1989) and 1% in the N.N.I.S. 
report (Isenberg, 1988). 
Compared to the other S.A. hospitals, P. mirabilis isolates from PHPE were found to be 
similar or marginally more resistant (Table 3.52.). 
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P. mirabilis isolates from urine specimens showed over 60% resistance to ampicillin, 
cotrimoxazole and sulphonamides, and over 90% to nitrofurantoin (Table 3.34., 
Figure 3.47.). Isolates showed a consistently higher susceptibility to nalidixic acid and 
nicene over the three year period. In 1991, the OPD isolates showed a higher 
percentage resistance than the whole hospital to the aforementioned agents. In a survey 
from patients in a district general hospital and local co=unity in the United Kingdom, 
McGowan et ai (1993) reported resistance figures of approximately 20% for P. mirabilis 
isolates to ampicillin and sulphonamides, this being quite low compared to the isolates 
from PHPE urine isolates. 
4.8. PSEUDOMONAS AERUGINOSA 
The mean percent resistance for P. aeruginosa isolates as shown by Figures 3.51. and 
3.52. is below 10% except for imipenem (12%, whole hospital and 23%, ICU) for both 
the whole hospital and ICU. The mean gentamicin resistance (6%) is lower than other 
studies (Isenberg, 1988; Moaz et ai., 1989; Neeling et ai., 1987). Compared to other S.A. 
hospitals, P. aeruginosa isolates from PHPE show a lower percent resistance except for 
ciprofloxacin (5%). In Universitas and Hillbrow hospitals ciprofloxacin resistance is 
reported to be lower than PHPE, as shown in Table 3.54. 
P. aeruginosa isolates from urine specimens showed a slightly higher mean percent 
resistance to gentamicin and tobramycin than those isolated from non-urinary sites and 
were very susceptible to the other agents tested. 
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4.9. SERRATIA MARCESCENS 
Over 80% of S. marcescens isolates showed resistance to ampicillin and tetracycline. 
The mean gentamicin resistance is similar to that found in Riyadh (Moaz et al., 1989) 
and higher than that reported in the N.N.I.S. sUIvey (Isenberg, 1988) (Figure 3.55.). 
Isenberg, (1988) also reported 71% and 14% resistance to cefamandole and piperacillin 
respectively which are higher than those found in this study; 30% and 4,5% respectively. 
Compared to other S.A. hospitals, S. marcescens isolates were more resistant than 
Universitas, lower than Red Cross Childrens' Hospital and similar to Hillbrow Hospital 
except amikacin (11 %) which had the highest percentage resistance of all the hospitals 
(Table 3.53.). 
4.10. XANTHOMONAS MALTOPHILIA 
This study has shown an increase in resistance of X maltophilia isolates to most of the 
agents and over 50% resistance to the aminoglycosides and imipenem (Figure 3.57.). 
Ceftazidime showed a decrease, 1990 to 1991, and it will be interesting to see if this 
trend continues. Compared with other S.A. hospitals percentage resistance to amikacin 
and the quinolones were found to be higher in this study (Table 3.55.). 
142 
4.11. COLIFORMS ISOLATED FROM URINE SPECIMENS 
Nicene has shown good activity against coliforms, the only agent below 10 percent 
resistance for both the whole hospital and OPD. Figures in this study compared to the 
survey from the United Kingdom (McGowan et al., 1993), shows higher resistance to 
ampicillin (80%) and nitrofurantoin (50%) (Figures 3.58., 3.59., and Table 3.44.). 
4.12. INTENSIVE CARE 
The methicillin sensitive staphylococcal isolates from the whole hospital are more 
resistant than those isolated from the ICU only, especially to cefamandole, tetracycline, 
cotrimoxazole and fucidin (Tables 3.2. and 3.6.). However, the methicillin resistant 
isolates from the ICU were more resistant than those isolated from the whole hospital 
(Tables 3.3. and 3.7.). E. faecalis was more resistant in hospital isolates to ampicillin, 
tetracycline and erythromycin and in the ICU isolates, to penicillin and piperacillin 
(Table 3.8.). 
Amongst the Gram-negative bacilli,A. anitratus andP. aerugirwsa isolates from the ICU 
are more resistant to all the agents than those from the whole hospital (Tables 3.16. and 
3.37.). Imipenem showed double the percent resistance in lCU (22.5%) than the whole 
hospital (11.5%) to P. aerugirwsa strains. 
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Overall the ICU isolates are more resistant to piperacillin, clindamycin, second and third 
generation cephalosporins, the aminoglycosides, the quinolones and imipenem. The 
whole hospital isolates are more resistant to ampicillin and tetracycline and there is 
similarity to cotrimoxazole, erythromycin, fucidin and penicillin between the whole 
hospital and ICU isolates. 
Shah et ai (1991) reported the susceptibilities of Gram-negative aerobes from Intensive 
Care Units of ten German hospitals and in comparison to this study, A. anitratus, 
E. cloacae, K aerogenes, P. mirabilis and E. coli isolates from PHPE are more resistant, 
the exception being to piperacillin which showed higher percent resistance compared to 
our figures. 
P. aeruginosa isolates from PHPE proved to be more sensitive than those from the 
German hospitals cited by Shah et ai., (1991) except for imipenem which showed 17% 
resistance in the German study compared to 22.5% in this study. In 1990 it was 
reported from the neonatal ICU at Baragwanath Hospital that 13% of Gram-negative 
bacilli were resistant to amikacin (Iiebowitz & Koornhof, 1990). This study showed a 
5,6% resistance to amikacin from the ICU at PHPE. 
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4.13. ANTIBIOTIC USAGE 
The antibiotics which could be evaluated for an increase or decrease in usage, showed 
an overall increase except for piperacillin, cotrimoxazole, gentamicin, amikacin and 
ceftazidime. The top three agents according to usage are: 1. cefoxitin; 2. 
aminoglycosides and 3. cefamandole proving that the general statement made by the 
Chief Pharmacist was indeed a fact. 
Amikacin is the aminoglycoside with the least percent resistance for both the whole 
hospital and the ICU. Excluding the figures for X maltophilia the following are the 
percent resistance to the aminoglycosides: amikacin 5%, tobramycin 18% and 
gentamicin 20%. This is similar to the findings at Tygerberg hospital (Hesseling, 1993). 
When an analysis and comparison of resistance patterns was done regarding changes 
within months and years it was found that the monthly changes were too erratic to be 
meaningful. However, year by year changes showed very significant increases and 
decreases in a few organisms to antibiotics of major significance. These changes are 
reflected in Table 3.47. and it shows that E. cloacae, A. anitratus and X maltophilia are 
the organisms in which there are statistically significant increases over the period 1989 
to 1991. 
It is of major importance that antibiotics to which organisms show an increase or 
decrease in percent resistance, are able to be monitored for usage patterns as changes 
in annual resistance patterns must be accounted for. In order to do this, accurate 
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records of drug usage is needed and as this data was not available over this three year 
period, it was impossible to correlate this very important aspect of the research project. 
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CHAPTERS 
5. CONCLUSION 
Bacterial resistance to antimicrobial agents has clinical and financial implications for the 
treatment of infected patients in hospitals. Over the three year period 1989 to 1991, 
antibiotic resistance patterns were monitored in PHPE. The changes were analysed for 
statistical significance and comparisons made between the whole hospital and the ICU. 
The ICU isolates tended to be more resistant than those from the whole hospital. 
Comparisons with other studies reported from South Africa and abroad were made. 
Overall, PHPE's resistance figures are considered to be low and the hospital is in a 
fortunate position in that the resistance problem is in the early stage and with good 
prescribing techniques, the resistance factor can be controlled (Professor AGS Gous, 
Clinical Pharmacist Baragwanath Hospital: personal communication). 
The development of this project's computer program for recording and analysing the 
results and the installation of a computer system in the microbiology department serving 
the hospital, has lead to a more sophisticated, user friendly, menu driven epidemiology 
program for handling large numbers of in vitro susceptibility tests performed on clinical 
isolates. This will enable the laboratory to accumulate a large database of local 
resistance patterns to the benefit of doctors, pharmacists and most important of all, the 
patients. 
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As part of this studies objectives, feedback was made to the medical staff and the 
observations were largely supported by the clinicians of the hospital. 
It is unfortunate that a meaningful comparison between antibiotic usage and bacterial 
resistance could not be made. This was largely due to the fact that this area has been 
neglected by the hospital. Stock sheets for each ward were not accurately filled in and 
the manner in which the total usage was collated by the pharmacy was not easily 
interpreted as there are many different ways in which they recorded each item e.g. vials, 
boxes, tablets, suspensions, injectables. It is extremely important that this matter receive 
urgent attention and that one co=on factor be used to determine the usage either as 
per dose or per course. 
The implications for the future are that meaningful resistance figures on a annual basis 
should be provided and that accurate record-keeping of total antibiotic usage and of 
individual wards especially the leU should be mandatory. Decisions can thus be made 
as to whether there has been an over prescription or poor prescription of an antibiotic 
and on this basis, implement restrictions of the use of the antibiotic or 'antibiotic 
holidays.' 
The project showed that studies of this kind undertaken on an ongoing basis can be 
extremely valuable in guiding clinical prescription policy. Antibiotic resistance in clinical 
isolates can be simply captured from pathology laboratory reports and an attempt was 
made to correlate changing resistance with antibiotic usage patterns in the hospital but 
this was precluded by inadequate pharmacy record keeping. 
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Correlation of the change in resistance patterns with the changes of antibiotic usage 
should be the special objective of a hospital Pharmaceutical and Therapeutics committee. 
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